Personensuche

Es wurde 1 Person gefunden.

Dr. med. Wilfried Eberhardt

Funktionen

Mitglied/er, Innere Klinik (Tumorforschung)

Aktuelle Veranstaltungen

2023 SS

Vergangene Veranstaltungen (max. 10)

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

Artikel in Zeitschriften

Kraskowski, Oliver; Stratmann, Jan A.; Wiesweg, Marcel; Eberhardt, Wilfried; Metzenmacher, Martin; Schmid, Kurt Werner; Herold, Thomas; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Laue, Katharina; Zaun, Gregor; Kasper, Stefan; Hense, Jörg; Sebastian, Martin; Schuler, Martin; Pogorzelski, Michael

Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting

In: Journal of Cancer Research and Clinical Oncology (2023) in press

ISSN: 1432-1335; 0171-5216; 0084-5353; 0301-1585

Online Volltext: dx.doi.org/ (Open Access)
Griesinger, Frank; Hummel, Horst-Dieter; Schäfer, Harald; de Wit, Maike; Kaiser, Ulrich; Kern, Jens; Jänicke, Martina; Spring, Lisa; Zacharias, Stefan; Kaiser-Osterhues, Anja; Groth, Annika; Hipper, Annette; Zaun, Gregor; Müller, Lothar; Uhlig, Jens; Thomas, Michael; Sebastian, Martin; Eberhardt, Wilfried; Ababei, Juliana; Alt, Jürgen; Ammon, Andreas; Anhuf, Jürgen; Azeh, Ivo; Bauer, Stefan; Behringer, Dirk; Berger, Winfried; Bernhardt, Christiane; Bertram, Mathias; Boesche, Michael; Bohnet, Sabine; Bruch, Harald-Robert; Brückl, Wolfgang; Burkhard-Meier, Ulrike; Christopoulos, Petros; Däßler, Klaus-Ulrich; Dechow, Tobias; Depenbusch, Reinhard; Dietze, Lutz; Dommach, Markus; Dörfel, Steffen; Elender, Corinna; Elsel, Wolfgang; Emde, Till-Oliver; Faehling, Martin; Fietz, Thomas; Fischer, Jürgen R.; Flieger, Dimitri; Freidt, Anke; Freier, Werner; Frenzel, Christian; Fuchs, Florian; Fuchs, Roswitha; Gaska, Tobias; Gleiber, Wolfgang; Grah, Christian; Grohé, Christian; Groschek, Matthias; Güldenzoph, Björn; Günther, Andreas; Haas, Siegfried; Hackenthal, Matthias; Hagen, Volker; Hahn, Lars; Hannig, Carla Verena; Hansen, Richard; Harich, Hanns-Detlev; Heilmann, Monika; Heinrich, Kathrin; Hering-Schubert, Christiane; Heßling, Jörg; Hoffknecht, Petra; Hortig, Patricia; Hübner, Gerdt; Hutzschenreuter, Ulrich; Illmer, Thomas; Innig, Georg; Jaeschke, Bastian; Junghanß, Christian; Kamal, Haytham; Kambartel, Kato; Kimmich, Martin; Kingreen, Dorothea; Kirchen, Heinz; Klausmann, Martine; Klein, Ortwin; Kokowski, Konrad; Körber, Wolfgang; Kortsik, Cornelius; Koschel, Dirk; Krämer, Benoit; Krammer-Steiner, Beate; Laack, Eckart; Lamberti, Christof; Leistner, Rumo David; Losem, Christoph; Lück, Andreas; Maintz, Christoph; Martin, Kerstin; Medgenberg, Dirk; Metzenmacher, Martin; Meyer zum Büschenfelde, Christian; Meyn, Philipp; Moorahrend, Enno; Müller, Annette; Neise, Michael; Nückel, Holger; Nusch, Arnd; Overbeck, Tobias; Pelz, Henning; Petersen, Volker; Peuser, Bettina; Plath, Margarete; Randerath, Winfried J.; Rauh, Jacqueline; Reck, Martin; Reichert, Dietmar; Reinmuth, Niels; Reiser, Marcel; Repp, Roland; Reschke, Daniel; Rittmeyer, Achim; Rodemer, Yolanda; Sackmann, Sandra; Sadjadian, Parvis; Sandner, Reiner; Sauer, Annette; Schaudt, Christoph; Schlag, Rudolf; Schmidt, Burkhard; Schmitz, Stephan; Schröder, Jan; Schroeder, Michael; Schulze, Mathias; Schumann, Christian; Schütte, Wolfgang; Schwaiblmair, Martin; Schwindt, Peter Florian; Seese, Bernd; Seipelt, Gernot; Sorgenfrei, Thomas; Steiff, Johannes; Steiniger, Heike; Trarbach, Tanja; Tufman, Amanda; Vehling-Kaiser, Ursula; von der Heyde, Eyck; von Verschuer, Ulla; Waller, Cornelius; Wehler, Thomas; Weißenborn, Georg; Weißinger, Florian; Wermke, Martin; Wesseler, Claas; Wiegand, Jörg; Wilhelm, Stefan; Wilke, Jochen; Zahn, Mark-Oliver; Zaiss, Matthias; Zeth, Matthias

Prognostic factors in nonsmall cell lung cancer : insights from the German CRISP registry

In: European Respiratory Journal (ERJ) Jg. 61 (2023) Nr. 2,

ISSN: 0903-1936; 1399-3003

Online Volltext: dx.doi.org/ (Open Access)
Guberina, Maja; Guberina, Nika; Pöttgen, Christoph; Gauler, Thomas; Richlitzki, Cedric; Metzenmacher, Martin; Wiesweg, Marcel; Plönes, Till; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, Hubertus; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Stuschke, Martin; Eberhardt, Wilfried

Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer : focus on treatment selection and prognostic factors

In: Immunotherapy Jg. 14 (2022) Nr. 12, S. 927 - 944

ISSN: 1750-743X; 1750-7448

Online Volltext: dx.doi.org/ (Open Access)
Pfannschmidt, Joachim; Guckenberger, M.; Eberhardt, Wilfried

Konzepte beim oligometastasierten Lungenkarzinom

In: Die Onkologie Jg. 28 (2022) Nr. 12, S. 1078 - 1086

ISSN: 2731-7226; 2731-7234

Online Volltext: dx.doi.org/
Guberina, Nika; Pöttgen, Christoph; Schuler, Martin; Guberina, Maja; Stamatis, Georgios; Plönes, Till; Metzenmacher, Martin; Theegarten, Dirk; Gauler, Thomas; Darwiche, Kaid; Aigner, Clemens; Eberhardt, Wilfried; Stuschke, Martin

Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment

In: Radiation Oncology Jg. 17 (2022) Nr. 1,

ISSN: 1748-717X

Online Volltext: dx.doi.org/ (Open Access)
Guberina, Maja; Herrmann, Ken; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Karpf-Wissel, Rüdiger; Santiago Garcia, Alina; Darwiche, Kaid; Stuschke, Martin

Prediction of malignant lymph nodes in NSCLC by machine-learning classifiers using EBUS-TBNA and PET/CT

In: Scientific Reports Jg. 12 (2022) Nr. 1,

ISSN: 2045-2322

Online Volltext: dx.doi.org/ (Open Access)
Scheffler, Matthias; Wiesweg, Marcel; Michels, Sebastian; Nogová, Lucia; Kron, Anna; Herold, Thomas; Scheel, Andreas H.; Metzenmacher, Martin; Eberhardt, Wilfried; Reis, Henning; Fassunke, Jana; Darwiche, Kaid; Aigner, Clemens; Schaufler, Diana; Riedel, Richard; Fischer, Rieke; Koleczko, Sophia; Schildhaus, Hans-Ulrich; Merkelbach-Bruse, Sabine; Schmid, Kurt Werner; Büttner, Reinhard; Wolf, Jürgen; Schuler, Martin

Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implications

In: Lung Cancer Jg. 168 (2022) S. 10 - 20

ISSN: 1872-8332; 0169-5002

Online Volltext: dx.doi.org/
Stamatis, Georgios; Müller, Stefanie; Weinreich, Gerhard; Schwarz, Birte; Eberhardt, Wilfried; Pöttgen, Christoph; Aigner, Clemens

Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatment

In: European Journal of Cardio-Thoracic Surgery Jg. 61 (2022) Nr. 2, S. 269 - 276

ISSN: 1873-734X; 1010-7940; 1567-4258; 1878-3309

Online Volltext: dx.doi.org/
Wiesweg, Marcel; Eberhardt, Wilfried; Schuler, Martin; Plönes, Till

Therapie früher und lokal fortgeschrittener Stadien des nicht-kleinzelligen Lungenkarzinoms

In: Die Innere Medizin Jg. 63 (2022) Nr. 7, S. 717 - 723

ISSN: 2731-7080; 2731-7099

Online Volltext: dx.doi.org/
Metzenmacher, Martin; Kopp, Hans-Georg; Griesinger, Frank; Reinmuth, Niels; Sebastian, Martin; Serke, Monika; Waller, Cornelius Florian; Thomas, Michael; Eggert, Jochen; Schmid-Bindert, Gerald; Hoiczyk, Mathias; Christoph, Daniel; Kimmich, Martin; Deuß, Burkhard; Seifert, Stephanie; Held, Swantje; Schuler, Martin; Herold, Thomas; Breitenbücher, Frank; Eberhardt, Wilfried

A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer

In: Therapeutic Advances in Medical Oncology Jg. 13 (2021)

ISSN: 1758-8359; 1758-8340

Online Volltext: dx.doi.org/ Online Volltext (Open Access)
Metzenmacher, Martin; Goetz, Moritz; Herold, Thomas; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Eberhardt, Wilfried; Schuler, Martin; Wiesweg, Marcel

Acquired Resistance to BRAF/MEK Inhibitor Therapy in BRAF-V⁶⁰⁰-mutated Squamous Cell Lung Cancer : Concurrent Evolvement of PTEN and MEK1 Mutations

In: Clinical Lung Cancer Jg. 22 (2021) Nr. 5, S. E668 - E672

ISSN: 1938-0690; 1525-7304

Online Volltext: dx.doi.org/
Wiesweg, Marcel; Preuß, Cedric; Roeper, Julia; Metzenmacher, Martin; Eberhardt, Wilfried; Stropiep, Ursula; Wedeken, Katrin; Reis, Henning; Herold, Thomas; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Schildhaus, Hans-Ulrich; Schmid, Kurt Werner; Falk, Markus; Heukamp, Lukas; Tiemann, Markus; Griesinger, Frank; Schuler, Martin

BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy

In: European Journal of Cancer Jg. 149 (2021) S. 211 - 221

ISSN: 1879-0852; 0959-8049

Online Volltext: dx.doi.org/
Griesinger, Frank; Eberhardt, Wilfried; Nusch, Arnd; Reiser, Marcel; Zahn, Mark-Oliver; Maintz, Christoph; Bernhardt, Christiane; Losem, Christoph; Stenzinger, Albrecht; Heukamp, Lukas C.; Büttner, Reinhard; Marschner, Norbert; Jänicke, Martina; Fleitz, Annette; Spring, Lisa; Sahlmann, Jörg; Karatas, Aysun; Hipper, Annette; Weichert, Wilko; Heilmann, Monika; Sadjadian, Parvis; Gleiber, Wolfgang; Grah, Christian; Waller, Cornelius F.; Reck, Martin; Rittmeyer, Achim; Christopoulos, Petros; Sebastian, Martin; Thomas, Michael

Biomarker testing in non-small cell lung cancer in routine care : Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

In: Lung Cancer Jg. 152 (2021) S. 174 - 184

ISSN: 1872-8332; 0169-5002

Online Volltext: dx.doi.org/ (Open Access)
Ferdinandus, Justin; Metzenmacher, Martin; Kessler, Lukas; Umutlu, Lale; Aigner, Clemens; Karl, Kambartel Otto; Grünwald, Viktor; Eberhardt, Wilfried; Fendler, Wolfgang Peter; Herrmann, Ken; Faehling, Martin; Christoph, Daniel

Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapy

In: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. 3, S. 002262

ISSN: 2051-1426

Online Volltext: dx.doi.org/ Online Volltext (Open Access)
Griesinger, Frank; Eberhardt, Wilfried; Nusch, Arnd; Reiser, Marcel; Zahn, Mark-Oliver; Maintz, Christoph; Bernhardt, Christiane; Losem, Christoph; Stenzinger, Albrecht; Heukamp, Lukas C.; Büttner, Reinhard; Marschner, Norbert; Jänicke, Martina; Fleitz, Annette; Spring, Lisa; Sahlmann, Jörg; Karatas, Aysun; Hipper, Annette; Weichert, Wilko; Heilmann, Monika; Sadjadian, Parvis; Gleiber, Wolfgang; Grah, Christian; Waller, Cornelius F.; Reck, Martin; Rittmeyer, Achim; Christopoulos, Petros; Sebastian, Martin; Thomas, Michael

Corrigendum to "Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)" [Lung Cancer 152 (2021) 174-184

In: Lung Cancer Jg. 157 (2021) S. 167

ISSN: 1872-8332; 0169-5002

Online Volltext: dx.doi.org/ (Open Access)
Schotten, Lea M.; Darwiche, Kaid; Seweryn, Michal; Yildiz, Vedat; Kneuertz, Peter J.; Eberhardt, Wilfried; Eisenmann, Stephan; Welter, Stefan; Sisson, Brianna E.; Pietrzak, Maciej; Wiesweg, Marcel; Plönes, Till; Hager, Thomas; He, Kai; Freitag, Lutz; Aigner, Clemens; Taube, Christian; Oezkan, Filiz

DNA methylation of PTGER4 in peripheral blood plasma helps to distinguish between lung cancer, benign pulmonary nodules and chronic obstructive pulmonary disease patients

In: European Journal of Cancer Jg. 147 (2021) S. 142 - 150

ISSN: 0959-8049; 0959-8049

Online Volltext: dx.doi.org/
Aigner, Clemens; Brüning, T.; Eberhardt, Wilfried; Härter, M.; Kaelberlah, Hans-Peter; Metzenmacher, M.; Shah, R.; Taube, Christian; Thomas, M.

Die aktuelle Therapie des asbestassoziierten malignen Pleuramesothelioms - Ein Experten-Konsensuspapier

In: Pneumologie Jg. 75 (2021) Nr. 10, S. 776 - 794

ISSN: 0934-8387; 1438-8790

Online Volltext: dx.doi.org/ (Open Access)
Borghaei, Hossein; Gettinger, Scott; Vokes, Everett E.; Chow, Laura Q M; Burgio, Marco Angelo; de Castro Carpeno, Javier; Pluzanski, Adam; Arrieta, Oscar; Frontera, Osvaldo Arén; Chiari, Rita; Butts, Charles; Wójcik-Tomaszewska, Joanna; Coudert, Bruno; Garassino, Marina Chiara; Ready, Neal; Felip, Enriqueta; García, Miriam Alonso; Waterhouse, David; Domine, Manuel; Barlesi, Fabrice; Antonia, Scott; Wohlleber, Markus; Gerber, David E.; Czyzewicz, Grzegorz; Spigel, David R.; Crino, Lucio; Eberhardt, Wilfried; Li, Ang; Marimuthu, Sathiya; Brahmer, Julie

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer

In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 7, S. 723 - 733

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/ (Open Access)
Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Ploenes, Till; Pöttgen, Christoph; Guberina, Nika; Herrmann, Ken; Umutlu, Lale; Wetter, Axel; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Schuler, Martin; Karpf-Wissel, Rüdiger; Stuschke, Martin

Impact of EBUS-TBNA in addition to [¹⁸F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLC

In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 2894 - 2903

ISSN: 1619-7089; 1619-7070

Online Volltext: dx.doi.org/ (Open Access)
Sebastian, Martin; Eberhardt, Wilfried; Hoffknecht, Petra; Metzenmacher, Martin; Wehler, Thomas; Kokowski, Konrad; Alt, Jürgen; Schütte, Wolfgang; Büttner, Reinhard; Heukamp, Lukas C.; Stenzinger, Albrecht; Jänicke, Martina; Fleitz, Annette; Zacharias, Stefan; Dille, Stephanie; Hipper, Annette; Sandberg, Marlen; Weichert, Wilko; Groschek, Matthias; von der Heyde, Eyck; Rauh, Jacqueline; Dechow, Tobias; Thomas, Michael; Griesinger, Frank

KRAS G12C-mutated advanced non-small cell lung cancer : A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

In: Lung Cancer Jg. 154 (2021) S. 51 - 61

ISSN: 1872-8332; 0169-5002

Online Volltext: dx.doi.org/ (Open Access)
Hautzel, Hubertus; Alnajdawi, Yazan; Fendler, Wolfgang; Rischpler, Christoph; Darwiche, Kaid; Eberhardt, Wilfried; Umutlu, Lale; Theegarten, Dirk; Stuschke, Martin; Schuler, Martin; Aigner, Clemens; Herrmann, Ken; Plönes, Till

N-staging in large cell neuroendocrine carcinoma of the lung : diagnostic value of [¹⁸F]FDG PET/CT compared to the histopathology reference standard

In: EJNMMI Research Jg. 11 (2021) Nr. 1,

ISSN: 2191-219X

Online Volltext: dx.doi.org/ (Open Access)
Harbeck, Nadia; Schneeweiss, Andreas; Thuss-Patience, Peter; Miller, Kurt; Garbe, Claus; Griesinger, Frank; Eberhardt, Wilfried; Klussmann, Jens P.; Wollenberg, Barbara; Grimm, Marc-Oliver; Zander, Thomas; Lüftner, Diana

Neoadjuvant and adjuvant end-points in health technology assessment in oncology

In: European Journal of Cancer (EJC) Jg. 147 (2021) S. 40 - 50

ISSN: 1879-0852; 0959-8049

Online Volltext: dx.doi.org/
Guberina, Maja; Darwiche, Kaid; Hautzel, Hubertus; Pöttgen, Christoph; Guberina, Nika; Gauler, Thomas; Ploenes, Till; Umutlu, Lale; Theegarten, Dirk; Aigner, Clemens; Eberhardt, Wilfried; Metzenmacher, Martin; Wiesweg, Marcel; Karpf-Wissel, Rüdiger; Schuler, Martin; Herrmann, Ken; Stuschke, Martin

Patterns of nodal spread in stage III NSCLC : Importance of EBUS-TBNA and ¹⁸F-FDG PET/CT for radiotherapy target volume definition

In: Radiation Oncology Jg. 16 (2021) Nr. 1,

ISSN: 1748-717X

Online Volltext: dx.doi.org/ (Open Access)
Guberina, Maja; Pöttgen, Christoph; Metzenmacher, Martin; Wiesweg, Marcel; Schuler, Martin; Aigner, Clemens; Ploenes, Till; Umutlu, Lale; Gauler, Thomas; Darwiche, Kaid; Stamatis, Georgios; Theegarten, Dirk; Hautzel, Hubertus; Jentzen, Walter; Guberina, Nika; Herrmann, Ken; Eberhardt, Wilfried E.E.; Stuschke, Martin

Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy

In: Journal of Nuclear Medicine (JNM) / Society of Nuclear Medicine and Molecular Imaging (SNMMI) (Hrsg.) Jg. 62 (2021) Nr. 12, S. 1684 - 1691

ISSN: 1535-5667; 0161-5505; 2159-662X; 0022-3123; 0097-9058

Online Volltext: dx.doi.org/ Online Volltext (Open Access)
Wessolly, Michael; Stephan-Falkenau, Susann; Streubel, Anna; Werner, Robert; Borchert, Sabrina; Griff, Sergej; Mairinger, Elena; Walter, Robert F. H.; Bauer, Torsten; Eberhardt, Wilfried E. E.; Blum, Torsten G.; Schmid, Kurt Werner; Kollmeier, Jens; Mairinger, Thomas; Mairinger, Fabian D.

A novel epitope quality-based immune escape mechanism reveals patient’s suitability for immune checkpoint inhibition

In: Cancer Management and Research Jg. 12 (2020) S. 7881 - 7890

ISSN: 1179-1322

Online Volltext: dx.doi.org/ (Open Access)
Wiesweg, Marcel; Herold, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Reis, Henning; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Herrmann, Ken; Nensa, Felix; Schildhaus, Hans-Ulrich; Schuler, Martin

Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutation

In: Lung Cancer Jg. 139 (2020) S. 165 - 168

ISSN: 1872-8332; 0169-5002

Online Volltext: dx.doi.org/
Guberina, Nika; Pöttgen, Christoph; Schuler, Martin; Guberina, Maja; Stamatis, Georgios; Plönes, Till; Krebs, Bettina; Metzenmacher, Martin; Theegarten, Dirk; Gauler, Thomas; Jöckel, Karl-Heinz; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Eberhardt, Wilfried

Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment : Only few risks left to improve

In: European Journal of Cancer Jg. 138 (2020) S. 156 - 168

ISSN: 1879-0852; 0959-8049

Online Volltext: dx.doi.org/
Reissig, Timm M.; Sara, Linda; Ting, Saskia; Reis, Henning; Metzenmacher, Martin; Eberhardt, Wilfried; Zaun, Gregor; Herold, Thomas; Aigner, Clemens; Darwiche, Kaid; Stuschke, Martin; Schildhaus, Hans-Ulrich; Schuler, Martin; Wiesweg, Marcel

ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancer

In: Lung Cancer Jg. 149 (2020) S. 10 - 16

ISSN: 1872-8332; 0169-5002

Online Volltext: dx.doi.org/
Stockhammer, Paul; Ho, Cassandra Su Lyn; Hegedus, Luca; Lotz, Gabor; Molnár, Eszter; Bankfalvi, Agnes; Herold, Thomas; Kalbourtzis, Stavros; Ploenes, Till; Eberhardt, Wilfried; Schuler, Martin; Aigner, Clemens; Schramm, Alexander; Hegedus, Balazs

HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model

In: Lung Cancer Jg. 144 (2020) S. 20 - 29

ISSN: 1872-8332; 0169-5002

Online Volltext: dx.doi.org/
Borchert, Sabrina; Suckrau, Pia-Maria; Walter, Robert F. H.; Wessolly, Michael; Mairinger, Elena; Steinborn, Julia; Hegedus, Balazs; Hager, Thomas; Herold, Thomas; Eberhardt, Wilfried; Wohlschläger, Jeremias; Aigner, Clemens; Bankfalvi, Agnes; Schmid, Kurt Werner; Mairinger, Fabian D.

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma

In: Scientific Reports Jg. 10 (2020) Nr. 1, S. 18677

ISSN: 2045-2322

Online Volltext: dx.doi.org/ (Open Access)
Wiesweg, Marcel; Mairinger, Fabian; Reis, Henning; Goetz, Moritz; Kollmeier, Jens; Misch, Daniel; Stephan-Falkenau, Susann; Mairinger, Thomas; Walter, Robert F.H.; Hager, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; Zaun, Gregor; Köster, Johannes; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Schmid, Kurt Werner; Rahmann, Sven; Schuler, Martin

Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context

In: European Journal of Cancer Jg. 140 (2020) S. 76 - 85

ISSN: 1879-0852; 0959-8049

Online Volltext: dx.doi.org/
Walter, Robert Fred Henry; Sydow, Saskia Roxanne; Berg, Erika; Kollmeier, Jens; Christoph, Daniel; Christoph, Sandra; Eberhardt, Wilfried; Mairinger, Thomas; Wohlschläger, Jeremias; Schmid, Kurt Werner; Mairinger, Fabian Dominik

Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesothelioma

In: Cancer Management and Research Jg. 11 (2019) S. 8711 - 8720

ISSN: 1179-1322

Online Volltext: dx.doi.org/ (Open Access)
Pöttgen, Christoph; Kleinhans, J.; Gauler, Thomas; Wrede, Karsten; Schuler, Martin; Aigner, Clemens; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin

Cerebral Recurrence after trimodal Therapy of Patients with locally advanced NSCLC - Prognostic Factors and prognostic Importance

In: Strahlentherapie und Onkologie Jg. 195 (2019) Nr. Suppl. 1, S. S66 - S67

ISSN: 0179-7158; 1439-099X
Borchert, Sabrina; Wessolly, Michael; Schmeller, Jan; Mairinger, Elena; Kollmeier, Jens; Hager, Thomas; Mairinger, Thomas; Herold, Thomas; Christoph, Daniel; Walter, Robert F. H.; Eberhardt, Wilfried; Plönes, Till; Wohlschläger, Jeremias; Aigner, Clemens; Schmid, Kurt Werner; Mairinger, Fabian D.

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

In: BMC Cancer Jg. 19 (2019) Nr. 1,

ISSN: 1471-2407

Online Volltext: dx.doi.org/ (Open Access)
Field, John K.; Dekoning, Harry; Oudkerk, Mattijs; Anwar, Sadia; Mulshine, James; Pastorino, Ugo; Eberhardt, Wilfried; Prosch, Helmut

Implementation of lung cancer screening in Europe: Challenges and potential solutions : Summary of a multidisciplinary roundtable discussion

In: ESMO Open Jg. 4 (2019) Nr. 5, S. 000577

ISSN: 2059-7029

Online Volltext: dx.doi.org/ (Open Access)
Wiesweg, Marcel; Mairinger, Fabian; Reis, Henning; Goetz, Moritz; Walter, Robert; Hager, Thomas; Metzenmacher, Martin; Eberhardt, Wilfried; McCutcheon, A.; Köster, J.; Stuschke, Martin; Aigner, Clemens; Darwiche, Kaid; Schmid, Kurt Werner; Rahmann, Sven; Schuler, Martin

Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancer

In: Annals of Oncology Jg. 30 (2019) Nr. 4, S. 655 - 657

ISSN: 1569-8041; 0923-7534

Online Volltext: dx.doi.org/ (Open Access)
Guberina, Maja; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Theegarten, Dirk; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph

Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trial

In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 7, S. 1439 - 1447

ISSN: 1619-7089; 1619-7070; 0340-6997

Online Volltext: dx.doi.org/
Guberina, M.; Stuschke, Martin; Eberhardt, Wilfried; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Dirk, T.; Jentzen, Walter; Herrmann, Ken; Pöttgen, Christoph

Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 Trial

In: International Journal of Radiation Oncology, Biology, Physics Jg. 105 (2019) Nr. 1, Supplement, S. 146 - S147

ISSN: 1879-355X

Online Volltext: dx.doi.org/ (Open Access)
Eberhardt, Wilfried; Stuschke, Martin; Aigner, Clemens; Pogorzelski, M.

Aktueller Stand der Diagnostik und Therapie des nichtkleinzelligen Lungenkarzinoms (NSCLC) im Stadium III

In: Der Onkologe Jg. 24 (2018) Nr. 12, S. 974 - 982

ISSN: 0947-8965

Online Volltext: dx.doi.org/
Griesinger, Frank; Roeper, Julia; Pöttgen, Christoph; Willborn, Kay C.; Eberhardt, Wilfried

Brain metastases in ALK-positive NSCLC - Time to adjust current treatment algorithms

In: OncoTarget Jg. 9 (2018) Nr. 80, S. 35181 - 35194

ISSN: 1949-2553

Online Volltext: dx.doi.org/ (Open Access)
Rami-Porta, Ramón; Eberhardt, Wilfried

Clinical implications of the innovations in the primary tumour and metastasis of the 8th edition of the TNM classification for lung cancer

In: Journal of Thoracic Disease Jg. 10 (2018) Nr. Suppl. 22, S. S2682 - S2685

ISSN: 2077-6624; 2072-1439

Online Volltext: dx.doi.org/ Online Volltext (Open Access)
Blumenthal, Gideon M.; Bunn, Paul A.; Chaft, Jamie E.; McCoach, Caroline E.; Perez, Edith A.; Scagliotti, Giorgio V.; Carbone, David P.; Aerts, Hugo J.W.L.; Aisner, Dara L.; Bergh, Jonas; Berry, Donald A.; Jarkowski, Anthony; Botwood, Nicholas; Cross, Darren A.E.; Diehn, Max; Drezner, Nicole L.; Doebele, Robert C.; Blakely, Collin M.; Eberhardt, Wilfried; Felip, Enriqueta; Gianni, Luca; Keller, Steven P.; Leavey, Patrick J.; Malik, Shakun; Pignatti, Francesco; Prowell, Tatiana M.; Redman, Mary W.; Rizvi, Naiyer A.; Rosell, Rafael; Rusch, Valerie; de Ruysscher, Dirk; Schwartz, Lawrence H.; Sridhara, Rajeshwari; Stahel, Rolf A.; Swisher, Stephen; Taube, Janis M.; Travis, William D.; Keegan, Patricia; Wiens, Jacinta R.; Wistuba, Ignacio I.; Wynes, Murry W.; Hirsch, Fred R.; Kris, Mark G.

Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer

In: Journal of Thoracic Oncology Jg. 13 (2018) Nr. 12, S. 1818 - 1831

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Bogner, Simon; Schmid, Kurt Werner; Metzenmacher, Martin; Hager, Thomas; Herrmann, Ken; Walter, Robert; Hegedues, Balazs; Herold, Thomas; Eberhardt, Wilfried; Reis, Henning; Goetz, Moritz; Mairinger, Fabian Dominik; Wiesweg, Marcel; Darwiche, Kaid; Aigner, Clemens; Schuler, Martin

Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX)

In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 15 Suppl., S. e15121

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Nicholson, Andrew G.; Tsao, Ming S.; Travis, William D.; Patil, Deepa T.; Galateau-Salle, Francoise; Marino, Mirella; Dacic, Sanja; Beasley, Mary Beth; Butnor, Kelly J.; Yatabe, Yasushi; Pass, Harvey I.; Rusch, Valerie W.; Detterbeck, Frank C.; Asamura, Hisao; Rice, Thomas W.; Rami-Porta, Ramon; Goldstraw, Peter; Ball, David; Beer, David; Beyruti, Ricardo; Bolejack, Vanessa; Chansky, Kari; Crowley, John; Eberhardt, Wilfried; Edwards, John; Giroux, Dorothy; Gleeson, Fergus; Groome, Patti; Huang, James; Kennedy, Catherine; Kim, Jhingook; Kim, Young Tae; Kingsbury, Laura; Kondo, Haruhiko; Krasnik, Mark; Kubota, Kaoru; Lerut, Toni; Lyons, Gustavo; Marom, Edith M.; Van Meerbeeck, Jan; Mitchell, Alan; Nakano, Takashi; Nowak, Anna; Peake, Michael; Rosenzweig, Kenneth; Ruffini, Enrico; Saijo, Nagahiro; Van Schil, Paul; Sculier, Jean-Paul; Shemanski, Lynn; Stratton, Kelly; Suzuki, Kenji; Tachimori, Yuji; Thomas, Charles F.; Turrisi, Andrew; Vansteenkiste, Johan; Watanabe, Hirokazu; Wu, Yi-Long; Bankier, Alex; Flieder, Douglas B.; Goo, Jin Mo; MacMahon, Heber; Naidich, David; Powell, Charles A.; Prokop, Mathias; Arenberg, Douglas A.; Donington, Jessica S.; Franklin, Wilbur A.; Girard, Nicolas; Mazzone, Peter J.; Tanoue, Lynn T.; Baas, Paul; Erasmus, Jeremy; Hasegawa, Seiki; Inai, Kouki; Kernstine, Kemp; Kindler, Hedy; Krug, Lee; Nackaerts, Kristiaan; Rice, David; Falkson, Conrad; Filosso, Pier Luigi; Giaccone, Giuseppe; Kondo, Kazuya; Lucchi, Marco; Okumura, Meinoshin; Blackstone, Eugene; Geisinger, Kim; Borczuk, Alain; Warth, Arne; Lantuejoul, Sylvie; Russell, Prudence; Thunnissen, Erik; Marchevsky, Alberto; Mino-Kenudson, Mari; Botling, Johan; Noguchi, Masayuki; Kerr, Keith; Hirsch, Fred R.; Chirieac, Lucian; Wistuba, Ignacio I.; Moreira, Andre; Chung, Jin-Haeng; Chou, Teh Ying; Bubendorf, Lukas; Chen, Gang; Pelosi, Giuseppe; Poleri, Claudia

Eighth edition staging of thoracic malignancies : Implications for the reporting pathologist

In: Archives of Pathology and Laboratory Medicine Jg. 142 (2018) Nr. 5, S. 645 - 661

ISSN: 1543-2165; 0003-9985

Online Volltext: dx.doi.org/ (Open Access)
Mucha, M. A.; Abu Jawad, Jehad; Gauler, Thomas; Eberhardt, Wilfried; Guberina, M.; Stuschke, Martin; Pöttgen, Christoph

Final Re-irradiation of Patients with NSCLC after primary high-dose Local Therapy

In: Strahlentherapie und Onkologie Jg. 194 (2018) Nr. Suppl.1, S. S59

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/ (Open Access)
Ishiba, Toshiyuki; Hoffmann, Andreas-Claudius; Usher, Joshua; Elshimali, Yahya; Sturdevant, Todd; Dang, Mai; Jaimes, Yolanda; Tyagi, Rama; Gonzales, Ronald; Grino, Mary; Pinski, Jacek K.; Barzi, Afsaneh; Raez, Luis E.; Eberhardt, Wilfried; Theegarten, Dirk; Lenz, Heinz-Josef; Uetake, Hiroyuki; Danenberg, Peter V.; Danenberg, Kathleen

Frequencies and expression levels of programmed death ligand 1 (PD-L1) in circulating tumor RNA (ctRNA) in various cancer types

In: Biochemical and Biophysical Research Communications Jg. 500 (2018) Nr. 3, S. 621 - 625

ISSN: 1090-2104; 0006-291X

Online Volltext: dx.doi.org/ Online Volltext (Open Access)
Mairinger, Fabian D.; Schmeller, Jan; Borchert, Sabrina; Wessolly, Michael; Mairinger, Elena; Kollmeier, Jens; Hager, Thomas; Mairinger, Thomas; Christoph, Daniel; Walter, Robert F.H.; Eberhardt, Wilfried; Plönes, Till; Wohlschläger, Jeremias; Jasani, Bharat; Schmid, Kurt Werner; Bankfalvi, Agnes

Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy

In: OncoTarget Jg. 9 (2018) Nr. 32, S. 22254 - 22268

ISSN: 1949-2553

Online Volltext: dx.doi.org/ (Open Access)
Walter, Robert F. H.; Werner, Robert; Wessolly, Michael; Mairinger, Elena; Borchert, Sabrina; Schmeller, Jan; Kollmeier, Jens; Mairinger, Thomas; Hager, Thomas; Bankfalvi, Agnes; Christoph, Daniel; Eberhardt, Wilfried; Plönes, Till; Aigner, Clemens; Schmid, Kurt Werner; Wohlschläger, Jeremias; Mairinger, Fabian D.

Inhibition of MDM2 via Nutlin-3A : A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53

In: Journal of Oncology (2018)

ISSN: 1687-8469; 1687-8450

Online Volltext: dx.doi.org/ (Open Access)
Nadjm, S.; Pöttgen, Christoph; Gauler, Thomas; Exner, J. P.; Krebs, B.; Cheufou, D.; Umutlu, Lale; Deuschl, C.; Darwiche, Kaid; Schuler, Martin; Eberhardt, Wilfried; Stuschke, Martin

Investigations of Long-term Survivors with locally advanced NSCLC on Morbidity of curative Therapy - Analysis of neurocognitive Effects

In: Strahlentherapie und Onkologie Jg. 194 (2018) Nr. Suppl. 1, S. 110

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/ (Open Access)
Reis, Henning; Metzenmacher, Martin; Goetz, Moritz; Savvidou, Nikoleta; Darwiche, Kaid; Aigner, Clemens; Herold, Thomas; Eberhardt, Wilfried; Skiba, Charlotte; Hense, Jörg; Virchow, Isabel; Westerwick, Daniela; Bogner, Simon; Ting, Saskia; Kasper, Stefan; Stuschke, Martin; Nensa, Felix; Herrmann, Ken; Hager, Thomas; Schmid, Kurt Werner; Schuler, Martin; Wiesweg, Marcel

MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and Immunotherapy

In: Clinical Lung Cancer Jg. 19 (2018) Nr. 4, S. e441 - e463

ISSN: 1938-0690; 1525-7304

Online Volltext: dx.doi.org/
Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Aigner, Clemens; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph

Pre-therapeutic metabolic Tumor Volume (MTV) in (18) F-FDG-PET/CT as a prognostic Factor in Patients with Stage IIIA-IIIB NSCLC before Trimodal Therapy or definitive Chemoradiotherapy - Results of Phase 3 Study

In: Strahlentherapie und Onkologie Jg. 194 (2018) Nr. Suppl.1, S. S41 - S42

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/ (Open Access)
Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Cheufou, D.; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph

Pretreatment metabolic volume in PET : Prognostic in lung cancer? German ESPATUE randomised phase3trial

In: Radiotherapy and Oncology (The Green Journal) Jg. 127 (2018) Nr. Suppl.1, S. S253 - S254

ISSN: 1879-0887; 0167-8140

Online Volltext: dx.doi.org/ (Open Access)
Wessolly, Michael; Walter, Robert F. H.; Vollbrecht, Claudia; Werner, Robert; Borchert, Sabrina; Schmeller, Jan; Mairinger, Elena; Herold, Thomas; Streubel, Anna; Christoph, Daniel; Eberhardt, Wilfried E. E.; Kollmeier, Jens; Mairinger, Thomas; Schmid, Kurt W.; Wohlschläger, Jeremias; Hager, Thomas; Mairinger, Fabian D.

Processing Escape Mechanisms Through Altered Proteasomal Cleavage of Epitopes Affect Immune Response in Pulmonary Neuroendocrine Tumors

In: Technology in Cancer Research & Treatment Jg. 17 (2018)

ISSN: 1533-0338; 1533-0346

Online Volltext: dx.doi.org/ (Open Access)
Oezkan, Filiz; Herold, Thomas; Darwiche, Kaid; Eberhardt, Wilfried; Worm, Karl; Christoph, Daniel; Wiesweg, Marcel; Freitag, Lutz; Schmid, Kurt Werner; Theegarten, Dirk; Hager, Thomas; Koenig, Michael J.; He, Kai; Taube, Christian; Schuler, Martin; Breitenbücher, Frank

Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma

In: Clinical Lung Cancer Jg. 19 (2018) Nr. 6, S. e879 - e884

ISSN: 1938-0690; 1525-7304

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Abu Jawad, Jehad; Gauler, Thomas; Guberina, M.; Darwiche, Kaid; Aigner, Clemens; Theegarten, Dirk; Schuler, Martin; Eberhardt, Wilfried; Stuschke, Martin

Sequential Dose Escalation Study NEOAHA for locally advanced NSCLC - Phase I-Results of Stage 1 (Integrated Boost-Radiation in neoadjuvant Therapy)

In: Strahlentherapie und Onkologie Jg. 194 (2018) Nr. Suppl. 1, S. S23 - S24

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/ (Open Access)
Pogorzelski, M.; Eberhardt, Wilfried

Therapie des nichtkleinzelligen Lungenkarzinoms im Stadium I–IIIC : Multimodale Konzepte mit kurativer Intention

In: Best Practice Onkologie Jg. 13 (2018) Nr. 3, S. 156 - 169

ISSN: 1862-8559; 0946-4565

Online Volltext: dx.doi.org/
Muehlenhoff, Lars; Dietel, Manfred; Thomas, Michael; Eberhardt, Wilfried; Schirmacher, Peter; Zirrgiebel, Ute; Schuette, Wolfgang

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany : an observational study

In: BMC Cancer Jg. 18 (2018) S. 135

ISSN: 1471-2407

Online Volltext: dx.doi.org/ (Open Access)
Eberhardt, Wilfried; Garassino, M. C.; Rizvi, N. A.; Janne, P. A.; Christoph, Daniel; Peters, S.; Toh, C. K.; Kurata, T.; Costa, E. C.; Koczywas, M.; Felip, E.; Chaft, J.; Qiu, J.; Kowanetz, M.; Coleman, S.; Mocci, S.; Sandler, A.; Gettinger, S.; Johnson, M. L.

Atezolizumab as 1L therapy for advanced NSCLC in PD-L1-selected patients : updated ORR, PFS and OS data from the BIRCH study

In: Oncology Research and treatment Jg. 40 (2017) Nr. Suppl. 5, S. 220

ISSN: 2296-5270; 0378-584X; 2296-5262; 1423-0240

Online Volltext: dx.doi.org/
Eberhardt, Wilfried

Checkpointinhibitoren beim nichtkleinzelligen Lungenkarzinom

In: Der Onkologe Jg. 23 (2017) Nr. 10, S. 838 - 844

ISSN: 0947-8965; 1433-0415

Online Volltext: dx.doi.org/
Griesinger, Frank; Eberhardt, Wilfried; Marschner, Norbert; Janicke, Martina; Hipper, Anette; Karatas, Aysun; Sebastian, Martin; Thomas, Michael; Schirmacher, Peter

Clinical Research Platform into Molecular Testing, Treatment, Outcome (CRISP) : A Prospective German Registry in Stage IV NSCLC AIO-TRK-0315

In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. Suppl. 1, S. S385

ISSN: 1556-1380; 1556-0864
Griesinger, F.; Eberhardt, Wilfried; Marschner, N.; Janicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Sebastian, M.; Thomas, M.

Clinical Research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma Patients (CRISP) : a prospective German Registry in stage IV NSCLC AIO-TRK-0315)

In: Annals of Oncology Jg. 28 (2017) Nr. Suppl. 5, S. 1385TiP

ISSN: 0923-7534; 1569-8041
Griesinger, F.; Eberhardt, Wilfried; Marschner, N.; Janicke, M.; Fleitz, A.; Sahlmann, J.; Karatas, A.; Hipper, A.; Sebastian, M.; Thomas, M.

Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma Patients (CRISP) : A prospective German registry in stage IV NSCLC, AIO-TRK-0315

In: Annals of Oncology Jg. 28 2 (2017) S. 125P

ISSN: 0923-7534; 1569-8041
Pöttgen, Christoph; Eberhardt, Wilfried; Stamatis, Georgios; Stuschke, Martin

Definitive radiochemotherapy versus surgery within multimodality treatment in stage III non-small cell lung cancer (NSCLC) - a cumulative meta-analysis of the randomized evidence

In: OncoTarget Jg. 8 (2017) Nr. 25, S. 41670 - 41678

ISSN: 1949-2553

Online Volltext: dx.doi.org/ (Open Access)
Christopoulos, Petros D.; Engel-Riedel, Walburga; Grohé, Christian M.; Kropf-Sanchen, Cornelia; von Pawel, Joachim V.; Gütz, Sylvia; Kollmeier, Jens; Eberhardt, Wilfried; Ukena, Dieter; Baum, Volker; Nimmrich, I.; Sieder, Christian; Schnabel, Philipp Albert; Serke, Monika Heidi Ursel; Thomas, Michael G.

Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma : A multicenter phase II trial

In: Annals of Oncology Jg. 28 (2017) Nr. 8, S. 1898 - 1902

ISSN: 1569-8041; 0923-7534

Online Volltext: dx.doi.org/
Mucha, M. A.; Pöttgen, Christoph; Moliavi, S.; Abu Jawad, Jehad; Gauler, Thomas; Christoph, Daniel; Eberhardt, Wilfried; Stuschke, Martin

Factors for the long-term Survival of Patients with NSCLC in the Stage of oligometastatic Disease after definitive Local Therapy

In: Strahlentherapie und Onkologie Jg. 193 (2017) Nr. Suppl. 1, S. 58

ISSN: 0179-7158; 1439-099X
Eberhardt, Wilfried; Rebmann, Vera; Rizvi, N.; Antonia, S. J.; Planchard, D.; Cappuzzo, F.; Mazieres, J.; Zalcman, G.; Lena, H.; Wolf, J.; Horn, L.; Stinchcombe, T.; Dy, G.; Blackwood-Chirchir, A.; Jin, C.; Geese, W. J.; Ramalingam, S. S.

First signal-finding study of soluble HLA-G and -E (sHLA-G/E) as potential prognostic markers of clinical outcome in advanced, refractory squamous-cell NSCLC (SCC) treated with nivolumab (NIVO) : checkMate 063

In: Oncology Research and treatment Jg. 40 (2017) Nr. Suppl. 3, S. 218 - 219

ISSN: 2296-5270; 0378-584X; 2296-5262; 1423-0240

Online Volltext: dx.doi.org/
Guberina, M.; Eberhardt, Wilfried; Stuschke, Martin; Gauler, Thomas; Heinzelmann, F.; Cheufou, D.; Kimmich, M.; Friedel, G.; Schmidberger, H.; Darwiche, Kaid; Jendrossek, Verena; Schuler, Martin; Stamatis, Georgios; Pöttgen, Christoph

Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA/B non-small-cell lung cancer : secondary analysis of a randomized trial

In: Annals of Oncology Jg. 28 (2017) Nr. 5, S. 1084 - 1089

ISSN: 1569-8041; 0923-7534

Online Volltext: dx.doi.org/ (Open Access)
Wiesweg, Marcel; Eberhardt, Wilfried; Reis, Henning; Ting, Saskia; Savvidou, Nikoleta; Skiba, Charlotte; Herold, Thomas; Christoph, Daniel; Meiler, Johannes; Worm, Karl; Kasper, Stefan; Theegarten, Dirk; Hense, Jörg; Hager, Thomas; Darwiche, Kaid; Oezkan, Filiz; Aigner, Clemens; Welter, Stefan; Kühl, Hilmar; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer

In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. 1, S. 54 - 64

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Schmidberger, H.; Heiss, M.; Eberhardt, Wilfried

Immunonkologie : Die sanfte Revolution der Krebsmedizin?

In: Der Onkologe Jg. 23 (2017) Nr. 10, S. 790 - 792

ISSN: 0947-8965; 1433-0415

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Eberhardt, Wilfried; Stuschke, Martin

Importance of neoadjuvant Radiotherapy in the trimodal Approach in the Treatment of locally advanced, potentially resectable NSCLC - a Meta-Analysis

In: Strahlentherapie und Onkologie Jg. 193 (2017) Nr. Suppl. 1, S. S62 - S63

ISSN: 0179-7158; 1439-099X
Guberina, M.; Pöttgen, Christoph; Abu Jawad, Jehad; Guberina, N.; Bucksch, D.; Cho, S. H.; Eberhardt, Wilfried; Stuschke, Martin

Intermodaler Vergleich von EBUS-TBNA, 18F-FDG PET/CT im Rahmen der Bestrahlungsplanung beim Lokal-fortgeschrittenen Nichtkleinzelligen Lungenkarzinom (Stadium II-IIIB)

In: Strahlentherapie und Onkologie Jg. 193 (2017) Nr. Suppl. 1, S. S20

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Thomas, M.; Kohlhaufl, M.; Reck, M.; Engel-Riedel, W.; Kortsik, C.; Bullinger, L.; Schneider, C. P.; Felip, E.; Brahmer, J.; Vokes, E.; Gettinger, S.; Geese, W.; Yoon, D.; Healey, D.; Li, A.; Eberhardt, Wilfried

Long-term outcomes with nivolumab in patients with previously treated advanced Non-Small Cell Lung Cancer (NSCLC)

In: Oncology Research and treatment Jg. 40 (2017) Nr. Suppl. 3, S. 137

ISSN: 2296-5270; 0378-584X; 2296-5262; 1423-0240

Online Volltext: dx.doi.org/
Griesinger, F.; Eberhardt, Wilfried; Nusch, A.; Reiser, M.; Losem, C.; Ketzler-Henkel, S.; Zahn, M. O.; Marschner, N.; Janicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Hipper, A.; Karatas, A.; de Wit, M.; Metzenmacher, M.; Waller, C. F.; Kern, J.; Weichert, W.; Sebastian, M.; Thomas, M.

Molecular testing, frequency of molecular alterations and first-line treatment of patients with non-small cell lung carcinoma (NSCLC) in Germany. First results from the prospective German Registry CRISP (AIO-TRK-0315)

In: Oncology Research and treatment Jg. 40 (2017) Nr. 3, S. 136 - 136

ISSN: 2296-5270; 0378-584X; 2296-5262; 1423-0240

Online Volltext: dx.doi.org/
Horn, Leora; Spigel, David R.; Vokes, Everett E.; Holgado, Esther; Ready, Neal; Steins, Martin; Poddubskaya, Elena; Borghaei, Hossein; Felip, Enriqueta; Paz-Ares, Luis; Pluzanski, Adam; Reckamp, Karen L.; Burgio, Marco A.; Kohlhäeufl, Martin; Waterhouse, David; Barlesi, Fabrice; Antonia, Scott; Arrieta, Oscar; Fayette, Jérôme; Crinò, Lucio; Rizvi, Naiyer; Reck, Martin; Hellmann, Matthew D.; Geese, William J.; Li, Ang; Blackwood-Chirchir, Anne; Healey, Diane; Brahmer, Julie; Eberhardt, Wilfried

Nivolumab versus docetaxel in previously treated patients with advanced non-small-cell lung cancer : Two-year outcomes from two randomized, open-label, phase III Trials (CheckMate 017 and CheckMate 057)

In: Journal of Clinical Oncology (JCO) Jg. 35 (2017) Nr. 35, S. 3924 - 3933

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/ Online Volltext (Open Access)
Pöttgen, Christoph; Guberina, M.; Abu Jawad, Jehad; Gauler, Thomas; Cordes, S.; Heinzelmann, F.; Schmidberger, H.; Darwiche, Kaid; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin

Prognostic Significance of Mean Lung Dose (MLD) in the dose-enhanced Radiochemotherapy of Local Advanced NSCLC - Analysis of ESPATU's Definitive Radiochemotherapy Arm

In: Strahlentherapie und Onkologie Jg. 193 (2017) Nr. 1, S. 20

ISSN: 0179-7158; 1439-099X
Oezkan, Filiz; Herold, Thomas; Darwiche, Kaid; Eberhardt, Wilfried; Christoph, Daniel; Worm, Karl; Freitag, Lutz; Schmid, Kurt Werner; Hager, Thomas; Breitenbücher, Frank; Schuler, Martin

Rapid and Highly Sensitive EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA Specimen of Lung Adenocarcinoma

In: Journal of Thoracic Oncology Jg. 12 (2017) Nr. Suppl. 1, S. S1201 - S1201

ISSN: 1556-1380; 1556-0864
Soria, Jean-Charles; Fülöp, A.; Maciel, C.; Fischer, J.R.; Girotto, G.; Lago, S.; Smit, E.; Ostoros, G.; Eberhardt, Wilfried; Lishkovska, P.; Lovick, S.; Mariani, G.; McKeown, A.; Kilgour, E.; Smith, P.; Bowen, K.; Kohlmann, A.; Carlile, D.J.; Jänne, P.A.

SELECT-2: A phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced or metastatic non-small-cell lung cancer

In: Annals of Oncology Jg. 28 (2017) Nr. 12, S. 3028 - 3036

ISSN: 1569-8041; 0923-7534

Online Volltext: dx.doi.org/ (Open Access)
Zarogoulidis, Paul; Petanidis, Savvas; Domvri, Kalliopi; Kioseoglou, Efrosini; Anestakis, Doxakis; Freitag, Lutz; Zarogoulidis, Konstantinos; Hohenforst-Schmidt, Wolfgang; Eberhardt, Wilfried

Autophagy inhibition upregulates CD4(+) tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation

In: Molecular Oncology Jg. 10 (2016) Nr. 10, S. 1516 - 1531

ISSN: 1878-0261; 1574-7891

Online Volltext: dx.doi.org/ (Open Access)
Köhler, Jens; Schuler, Martin; Gauler, Thomas; Nöpel-Dünnebacke, Stefanie; Ahrens, Maike; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, Maria; Breitenbücher, Frank; Cheufou, Danjouma; Özkan, Filiz; Darwiche, Kaid; Hoiczyk, Mathias; Reis, Henning; Welter, Stefan; Eberhardt, Wilfried; Eisenacher, Martin; Teschler, Helmut; Stamatis, Georgios; Schmiegel, Wolff; Hahn, Stephan Albrecht; Baraniskin, Alexander

Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients

In: Journal of Cancer Research and Clinical Oncology Jg. 142 (2016) Nr. 4, S. 795 - 805

ISSN: 0171-5216

Online Volltext: dx.doi.org/
Schuette, W; Dietel, M; Thomas, M; Eberhardt, Wilfried; Griesinger, F; Zirrgiebel, U; Radke, S; Schirmacher, P

Exonabhängige Subgruppenanalyse der nicht-interventionellen REASON-Studie : PFS und OS beim EGFR-mutierten NSCLC mit Behandlung von Gefitinib versus Chemotherapie

In: Pneumologie Jg. 70 (2016) Nr. 8, S. 514 - 521

ISSN: 0934-8387; 1438-8790

Online Volltext: dx.doi.org/
Heukamp, L; Menon, R; Müller, J; Lakis, S; Netchaeva, M; Griesinger, F; Eberhardt, Wilfried; Heuckmann, J M

NEOliquid : Detection of KIF5B-RET fusions in liquid biopsy samples

In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. Suppl. 4, S. 82 - 83

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/
Eberhardt, Wilfried; Mitchell, Alan; Rami-Porta, Ramon

Reply to the Letter to the Editor by Hendriks et al.

In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 3, S. e43 - e44

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Pöttgen, Christoph; Gauler, Thomas; Bellendorf, Alexander; Guberina, Maja; Bockisch, Andreas; Schwenzer, Nina; Heinzelmann, Frank; Cordes, Sebastian; Schuler, Martin H; Welter, Stefan; Stamatis, Georgios; Friedel, Godehard; Darwiche, Kaid; Jöckel, Karl-Heinz; Eberhardt, Wilfried; Stuschke, Martin

Standardized Uptake Decrease on [18F]-Fluorodeoxyglucose Positron Emission Tomography After Neoadjuvant Chemotherapy Is a Prognostic Classifier for Long-Term Outcome After Multimodality Treatment : Secondary Analysis of a Randomized Trial for Resectable Stage IIIA/B Non-Small-Cell Lung Cancer

In: Journal of Clinical Oncology (JCO) Jg. 34 (2016) Nr. 21, S. 2526 - 2533

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Schuette, W; Eberhardt, Wilfried; Waller, C; Schirmacher, P; Dietel, M; Zirrgiebel, U; Radke, S; Thomas, M

Subgruppenanalyse aus der nicht-interventionellen Beobachtungsstudie REASON : PFS und OS gemäß Alter, Raucherstatus, Geschlecht und histologischem Subtyp unter Verwendung von Gefitinib bzw. chemotherapeutischer Behandlung bei NSCLC-Patienten

In: Pneumologie Jg. 70 (2016) Nr. 9, S. 579 - 588

ISSN: 0934-8387; 1438-8790

Online Volltext: dx.doi.org/
Goldstraw, Peter; Chansky, Kari; Crowley, John; Rami-Porta, Ramon; Asamura, Hisao; Eberhardt, Wilfried; Nicholson, Andrew G; Groome, Patti; Mitchell, Alan; Bolejack, Vanessa; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee

The IASLC Lung Cancer Staging Project : Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 1, S. 39 - 51

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Detterbeck, Frank C; Nicholson, Andrew G; Franklin, Wilbur A; Marom, Edith M; Travis, William D; Girard, Nicolas; Arenberg, Douglas A; Bolejack, Vanessa; Donington, Jessica S; Mazzone, Peter J; Tanoue, Lynn T; Rusch, Valerie W; Crowley, John; Asamura, Hisao; Rami-Porta, Ramón; IASLC Staging and Prognostic Factors Committee; Eberhardt, Wilfried

The IASLC Lung Cancer Staging Project : Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification

In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 5, S. 639 - 650

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/
Travis, William D; Asamura, Hisao; Bankier, Alexander A; Beasley, Mary Beth; Detterbeck, Frank; Flieder, Douglas B; Goo, Jin Mo; MacMahon, Heber; Naidich, David; Nicholson, Andrew G; Powell, Charles A; Prokop, Mathias; Rami-Porta, Ramón; Rusch, Valerie; van Schil, Paul; Yatabe, Yasushi; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee; Eberhardt, Wilfried

The IASLC Lung Cancer Staging Project : Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 8, S. 1204 - 1223

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Detterbeck, Frank C; Bolejack, Vanessa; Arenberg, Douglas A; Crowley, John; Donington, Jessica S; Franklin, Wilbur A; Girard, Nicolas; Marom, Edith M; Mazzone, Peter J; Nicholson, Andrew G; Rusch, Valerie W; Tanoue, Lynn T; Travis, William D; Asamura, Hisao; Rami-Porta, Ramón; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup; Eberhardt, Wilfried

The IASLC Lung Cancer Staging Project : Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 5, S. 681 - 692

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/
Pass, Harvey; Giroux, Dorothy; Kennedy, Catherine; Ruffini, Enrico; Cangir, Ayten K; Rice, David; Asamura, Hisao; Waller, David; Edwards, John; Weder, Walter; Hoffmann, Hans; van Meerbeeck, Jan P; Rusch, Valerie W; Goldstraw, Peter; Rami-Porta, Ramón; Ball, David; Beer, David; Beyruti, Ricardo; Bolejack, Vanessa; Chansky, Kari; Crowley, John; Detterbeck, Frank; Eberhardt, Wilfried; Edwards, John; Galateau-Sallé, Françoise; Gleeson, Fergus; Groome, Patti; Huang, James; Kim, Jhingook; Kim, Young Tae; Kingsbury, Laura; Kondo, Haruhiko; Krasnik, Mark; Kubota, Kaoru; Lerut, Antoon; Lyons, Gustavo; Marino, Mirella; Marom, Edith M; van Meerbeeck, Jan; Mitchell, Alan; Nakano, Takashi; Nicholson, Andrew G; Nowak, Anna; Peake, Michael; Rosenzweig, Kenneth; Rusch, Valerie; Saijo, Nagahiro; Van Schil, Paul; Sculier, Jean-Paul; Shemanski, Lynn; Stratton, Kelly; Suzuki, Kenji; Tachimori, Yuji; Thomas, Charles F; Travis, William; Tsao, Ming S; Turrisi, Andrew; Vansteenkiste, Johan; Watanabe, Hirokazu; Wu, Yi-Long; Baas, Paul; Erasmus, Jeremy; Hasegawa, Seiki; Inai, Kouki; Kernstine, Kemp; Kindler, Hedy; Krug, Lee; Nackaerts, Kristiaan; Falkson, Conrad; Filosso, Pier Luigi; Giaccone, Giuseppe; Kondo, Kazuya; Lucchi, Marco; Okumura, Meinoshin; Blackstone, Eugene

The IASLC Mesothelioma Staging Project : Improving Staging of a Rare Disease Through International Participation

In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 12, S. 2082 - 2088

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/
Nowak, Anna K.; Chansky, Kari; Rice, David C; Pass, Harvey I; Kindler, Hedy L; Billé, Andrea; Rintoul, Robert C; Batirel, Hasan F; Thomas, Charles F; Friedberg, Joseph; Cedres, Susana; de Perrot, Marc; Rusch, Valerie W; Goldstraw, Peter; Rami-Porta, Ramón; Asamura, Hisao; Ball, David; Beer, David; Beyruti, Ricardo; Bolejack, Vanessa; Crowley, John; Detterbeck, Frank; Eberhardt, Wilfried; Edwards, John; Galateau-Sallé, Françoise; Giroux, Dorothy; Gleeson, Fergus; Groome, Patti; Huang, James; Kennedy, Catherine; Kim, Jhingook; Kim, Young Tae; Kingsbury, Laura; Kondo, Haruhiko; Krasnik, Mark; Kubota, Kaoru; Lerut, Antoon; Lyons, Gustavo; Marino, Mirella; Marom, Edith M; van Meerbeeck, Jan; Mitchell, Alan; Nakano, Takashi; Nicholson, Andrew G; Peake, Michael; Rosenzweig, Kenneth; Ruffini, Enrico; Saijo, Nagahiro; Van Schil, Paul; Sculier, Jean-Paul; Shemanski, Lynn; Stratton, Kelly; Suzuki, Kenji; Tachimori, Yuji; Thomas, Charles F; Travis, William; Tsao, Ming S; Turrisi, Andrew; Watanabe, Hirokazu; Wu, Yi-Long; Baas, Paul; Erasmus, Jeremy; Hasegawa, Seiki; Inai, Kouki; Kernstine, Kemp; Krug, Lee; Nackaerts, Kristiaan; Pass, Harvey; Falkson, Conrad; Filosso, Pier Luigi; Giaccone, Giuseppe; Kondo, Kazuya; Lucchi, Marco; Okumura, Meinoshin; Blackstone, Eugene

The IASLC Mesothelioma Staging Project : Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma

In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 12, S. 2089 - 2099

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Detterbeck, Frank C.; Franklin, Wilbur A.; Nicholson, Andrew G.; Girard, Nicolas; Arenberg, Douglas A.; Travis, William D.; Mazzone, Peter J.; Marom, Edith M.; Donington, Jessica S.; Tanoue, Lynn T.; Rusch, Valerie W.; Asamura, Hisao; Rami-Porta, Ramón; IASLC Staging and Prognostic Factors Committee; Eberhardt, Wilfried

The IASLC lung cancer staging project : Background data and proposed criteria to distinguish separate primary lung cancers from metastatic foci in patients with two lung tumors in the forthcoming eighth edition of the TNM classification for lung cancer

In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 5, S. 651 - 665

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/
Nicholson, Andrew; Rami-Porta, Ramon; van Meerbeeck, Jan; Eberhardt, Wilfried; Turrisi, Andrew; Kubota, Kaoru; Beyruti, Ricardo; Crowley, John; Chansky, Kari

The International Association for the Study of Lung Cancer Lung Cancer Staging Project : Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 3, S. 300 - 311

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Kreuter, Michael; Thomas, Michael; Griesinger, Frank; Stamatis, Georgios; Graeter, Thomas; Schumann, Christian; Thomeer, Michiel; Neumann, Silke; Reck, Martin; Frickhofen, Norbert; Serke, Monika; Kollmeier, Jens; Zabeck, Heike; Eberhardt, Wilfried; Fischer, Jürgen R.; Vansteenkiste, Johan; Engel-Riedel, Walburga

Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study)

In: Journal of Thoracic Oncology Jg. 11 (2016) Nr. 1, S. 85 - 93

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Kowanetz, M.; Li, Z.; Peters, S.; Kurata, T.; Johnson, M.; Eberhardt, Wilfried; Mocci, S.; Sandler, A.; Garassino, M.; Rizvi, N.A.; Toh, C.K.; Besse, B.; Janne, P.A.

16LBA Phase II, single-arm trial (BIRCH) of atezolizumab as first-line or subsequent therapy for locally advanced or metastatic PD-L1-selected non-small cell lung cancer (NSCLC)

In: European Journal of Cancer Jg. 51 (2015) Nr. Suppl. 3, S. S717 - S718

ISSN: 0959-8049

Online Volltext: dx.doi.org/
Eberhardt, Wilfried; De Ruysscher, Dirk De M.; Weder, Walter; Le Péchoux, Cécile; De Leyn, Paul De J.; Hoffmann, Hans Jürgen H.; Westeel, Virginie; Stahel, Rolf Arno; Felip, Enriqueta; Peters, Solange; Panel Members

2nd ESMO Consensus Conference in Lung Cancer : locally advanced stage III non-small-cell lung cancer

In: Annals of oncology Jg. 26 (2015) Nr. 8, S. 1573 - 1588

ISSN: 0923-7534; 1569-8041

Online Volltext: dx.doi.org/ (Open Access)
Spigel, David R.; Reckamp, Karen L.; Rizvi, Naiyer A.; Poddubskaya, Elena; West, Howard Jack; Eberhardt, Wilfried; Baas, Paul; Antonia, Scott Joseph; Pluzanski, Adam; Vokes, Everett E; Holgado, Esther; Waterhouse, David Michael; Ready, Neal; Gainor, Justin F.; Aren, Osvaldo Rudy; Horn, Leora; Paz-Ares, Luis; Baudelet, Christine; Lestini, Brian Joseph; Brahmer, Julie R.

A phase III study (CheckMate 017) of nivolumab (NIVO; anti-programmed death-1 [PD-1]) vs docetaxel (DOC) in previously treated advanced or metastatic squamous (SQ) cell non-small cell lung cancer (NSCLC)

In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15_suppl, S. 8009

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/ Online Volltext
Pöttgen, Christoph; Abu Jawad, Jehad; Gkika, Eleni; Freitag, Lutz; Lübcke, Wolfgang; Welter, Stefan; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried; Stamatis, Georgios; Stuschke, Martin

Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomy

In: Journal of Thoracic Disease Jg. 7 (2015) Nr. 3, S. 264 - 272

ISSN: 2072-1439

Online Volltext: dx.doi.org/
Kelly, Karen; Altorki, Nasser K; Eberhardt, Wilfried; O'Brien, Mary E R; Spigel, David R; Crinò, Lucio; Tsai, Chun-Ming; Kim, Joo-Hang; Cho, Eun Kyung; Hoffman, Philip C; Orlov, Sergey V; Serwatowski, Piotr; Wang, Jiuzhou; Foley, Margaret A; Horan, Julie D; Shepherd, Frances A

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT) : A Randomized, Double-Blind, Phase III Trial

In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 34, S. 4007 - 4014

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/ Online Volltext (Open Access)
Shepherd, Frances A.; Eberhardt, Wilfried; Altorki, Nasser K.; O'Brien, Mary E. R; Wang, Joe; Wu, Jun; Gill, Stan; Iwata, Kenneth; Richardson, Frank C.; Horan, Julie D.; Foley, Margaret A.; Kelly, Karen

Common and rare EGFR mutations (EGFRm) in the RADIANT trial : Final follow-up with 5 year data

In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15_suppl, S. 7539

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Eberhardt, Wilfried

Concurrent chemoradiotherapy in stage III non-small-cell lung cancer : what is the best regimen?

In: Journal of clinical oncology Jg. 33 (2015) Nr. 6, S. 532 - 533

ISSN: 0732-183X

Online Volltext: dx.doi.org/
Schütte, Wolfgang H. W.; Schirmacher, Peter; Eberhardt, Wilfried; Fischer, Jürgen R.; von der Schulenburg, J.-Matthias Graf; Mezger, Jörg; Schumann, Christian; Serke, Monika; Zaun, Silke; Dietel, Manfred; Thomas, Michael

EGFR mutation status and first-line treatment in patients with stage III/IV non-small cell lung cancer in Germany : An observational study

In: Cancer Epidemiology, Biomarkers & Prevention Jg. 24 (2015) Nr. 8, S. 1254 - 1261

ISSN: 1538-7755; 1055-9965

Online Volltext: dx.doi.org/ (Open Access)
O'Brien, Mary E. R.; Kelly, Karen; Altorki, Nasser K.; Eberhardt, Wilfried; Spigel, David R.; Crino, Lucio; Tsai, Chun-Ming; Kim, Joo-Hang; Cho, Eun Kyung; Hoffman, Philip C.; Keshavjee, Shaf; Orlov, Sergey; Serwatowski, Piot; Wang, Joe; Foley, Margaret A.; Horan, Julie D.; Shepherd, Frances A.

Final follow-up (f/u) results from RADIANT : A randomized double blind phase 3 trial of adjuvant erlotinib (E) versus placebo (P) following complete tumor resection in patients (pts) with stage IB-IIIA EGFR positive (IHC/FISH) non-small cell lung cancer (N

In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15_suppl, S. 7540

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/ Online Volltext
Gore, Martin; Szczylik, C.; Porta, C.; Bracarda, S.; Bjarnason, G. A.; Oudard, S.; Lee, S.-H.; Haanen, J.; Castellano, D.; Vrdoljak, E.; Schöffski, P.; Mainwaring, P.; Hawkins, R. E.; Crinò, L.; Kim, T. M.; Carteni, G.; Eberhardt, Wilfried; Zhang, K.; Fly, K.; Matczak, E.; Lechuga, M. J.; Hariharan, S.; Bukowski, R.

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

In: British Journal of Cancer (BJC) Jg. 113 (2015) Nr. 1, S. 12 - 19

ISSN: 1532-1827; 0007-0920

Online Volltext: dx.doi.org/ (Open Access)
Reis, Henning; Herold, Thomas; Ting, S.; Worm, Karl Heinz; Huber, U.; Christoph, Daniel; Eberhardt, Wilfried; Kostbade, K.; Kasper, Stefan; Stamatis, Georgios; Welter, Stefan; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Theegarten, Dirk; Schmidt, K. W.; Schuler, Martin; Wiesweg, Marcel

HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas

In: Lung Cancer Jg. 88 (2015) Nr. 1, S. 34 - 41

ISSN: 0169-5002

Online Volltext: dx.doi.org/
Eberhardt, Wilfried; Stuschke, Martin

Multimodal treatment of non-small-cell lung cancer

In: The Lancet Jg. 386 (2015) Nr. 9998, S. 1018 - 1020

ISSN: 0140-6736

Online Volltext: dx.doi.org/
Brahmer, Julie; Reckamp, Karen L; Baas, Paul; Crinò, Lucio; Eberhardt, Wilfried; Poddubskaya, Elena; Antonia, Scott; Pluzanski, Adam; Vokes, Everett E; Holgado, Esther; Waterhouse, David; Ready, Neal; Gainor, Justin; Arén Frontera, Osvaldo; Havel, Libor; Steins, Martin; Garassino, Marina C; Aerts, Joachim G; Domine, Manuel; Paz-Ares, Luis; Reck, Martin; Baudelet, Christine; Harbison, Christopher T; Lestini, Brian; Spigel, David R

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

In: The New England Journal of Medicine Jg. 373 (2015) Nr. 2, S. 123 - 135

ISSN: 1533-4406; 0028-4793

Online Volltext: dx.doi.org/
Joerger, Markus; Von Pawel, Joachim; Kraff, Stefanie; Fischer, Juergen R; Eberhardt, Wilfried; Gauler, Thomas; Mueller, Lothar; Reinmuth, Niels; Reck, Martin; Kimmich, Martin; Mayer, Frank; Kopp, Hans-Georg; Behringer, Dirk M.; Ko, Yon-Dschun; Frueh, Martin; Hilger, Ralf A.; Roessler, Max; Moritz, Berta; Jaehde, Ulrich

Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin in advanced non-small cell lung cancer (NSCLC) patient

In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 15_suppl, S. 8051

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/ Online Volltext
Eberhardt, Wilfried; Pöttgen, Christoph; Gauler, Thomas; Friedel, Godehard; Veit, Stefanie; Heinrich, Vanessa; Welter, Stefan; Budach, Wilfried; Spengler, Werner; Kimmich, Martin; Fischer, Berthold; Schmidberger, Heinz; De Ruysscher, Dirk; Belka, Claus; Cordes, Sebastian; Hepp, Rodrigo; Lütke-Brintrup, Diana; Lehmann, Nils; Schuler, Martin; Jöckel, Karl-Heinz; Stamatis, Georgios; Stuschke, Martin

Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)

In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 35, S. 4194 - 4201

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Stuschke, Martin; Graupner, Britta; Theegarten, Dirk; Gauler, Thomas; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, Eleni; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, Matthias; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried

Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors

In: BMC Cancer Jg. 15 (2015) Nr. 1, S. 363

ISSN: 1471-2407

Online Volltext: dx.doi.org/ (Open Access)
Eberhardt, Wilfried

Reply to D.A. Palma et al and A. Addeo et al

In: Journal of Clinical Oncology (JCO) Jg. 33 (2015) Nr. 26, S. 2929 - 2930

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Eberhardt, Wilfried; Mitchell, Alan; Crowley, John; Kondo, Haruhiko; Kim, Young Tae; Turrisi, Andrew; Goldstraw, Peter; Rami-Porta, Ramon

The IASLC Lung Cancer Staging Project : Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer

In: Journal of Thoracic Oncology Jg. 10 (2015) Nr. 11, S. 1515 - 1522

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Rami-Porta, Ramón; Bolejack, Vanessa; Crowley, John; Ball, David; Kim, Jhingook; Lyons, Gustavo; Rice, Thomas; Suzuki, Kenji; Thomas, Charles F.; Travis, William D.; Wu, Yi-Long; IASLC Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions.; Eberhardt, Wilfried

The IASLC lung cancer staging project : Proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer

In: Journal of Thoracic Oncology Jg. 10 (2015) Nr. 7, S. 990 - 1003

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Krug, Lee M.; Kindler, Hedy L.; Calvert, Hilary; Manegold, Christian; Tsao, Anne S.; Fennell, Dean; Öhman, Ronny; Plummer, Ruth; Eberhardt, Wilfried; Fukuoka, Kazuya; Gaafar, Rabab M.; Lafitte, Jean-Jacques; Hillerdal, Gunnar; Chu, Quincy; Buikhuisen, Wieneke A.; Lubiniecki, Gregory M.; Sun, Xing; Smith, Margaret; Baas, Paul

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014) : a phase 3, double-blind, randomised, placebo-controlled trial

In: The lancet oncology Jg. 16 (2015) Nr. 4, S. 447 - 456

ISSN: 1474-5488; 1470-2045

Online Volltext: dx.doi.org/
Vansteenkiste, J.; Crinò, L.; Dooms, C.; Douillard, J. Y.; Faivre-Finn, C.; Lim, E.; Rocco, G.; Senan, S.; van~Schil, P.; Veronesi, G.; Stahel, R.; Peters, S.; Felip, E.; Kerr, K.; Besse, B.; Eberhardt, Wilfried; Edelman, M.; Mok, T.; O'Byrne, K.; Novello, S.; Bubendorf, L.; Marchetti, A.; Baas, P.; Reck, M.; Syrigos, K.; Paz-Ares, L.; Smit, E.; Meldgaard, P.; Adjei, A.; Nicolson, M.; Weder, W.; Ruysscher, D. de; Le~Pechoux, C.; Leyn, P. de; Westeel, V.

2nd ESMO consensus conference on lung cancer : Early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

In: Annals of Oncology Jg. 25 (2014) Nr. 8, S. 1462 - 1474

ISSN: 1569-8041

Online Volltext: dx.doi.org/ (Open Access)
Kelly, K.; Altorki, N. K.; Eberhardt, Wilfried; O'Brien, MER; Spigel, D. R.; Crino, L.; Tsai, C. M.; Kim, J. H.; Cho, E. K.; Szczesna, A.; Burghuber, O.; Hoffman, P. C.; Keshavjee, S.; Orlov, S.; Serwatowski, P.; Wang, J. Z.; Foley, M. A.; Horan, J. D.; Park, J. W.; Shepherd, F. A.; Tarceva Radiant Investigator Grp

A randomized, double-blind phase 3 trial of adjuvant erlotinib (E) versus placebo (P) following complete tumor resection with or without adjuvant chemotherapy in patients (pts) with stage IB-IIIA EGFR positive (IHC/FISH) non-small cell lung cancer (NSCLC) : RADIANT results

In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 7501

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Altorki, N. K.; O'brien, MER; Eberhardt, Wilfried; Richardson, F. C.; Wang, J.; Foley, M. A.; Horan, J. D.; Shepherd, F. A.; Kelly, K.

Adjuvant Erlotinib (E) Versus Placebo (P) for Completely Resected Stage IB-IIIA EGFR-Positive (IHC/FISH) Non-Small Cell Lung Cancer (NSCLC) : RADIANT Results: Locally Advanced Non-Small Cell Lung Cancer

In: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 5 Suppl., S. S2 - S3

ISSN: 1879-355X; 0360-3016

Online Volltext: dx.doi.org/
Shepherd, F. A.; Altorki, N. K.; Eberhardt, Wilfried; O'Brien, Mary; Spigel, D. R.; Crino, L.; Tsai, C. M.; Kim, J. H.; Cho, E. K.; Szczesna, A.; Burghuber, O.; Hoffman, P. C.; Keshavjee, S.; Orlov, S.; Serwatowski, P.; Wang, J. Z.; Foley, M. A.; Horan, J. D.; Richardson, F. C.; Kelly, K.; Tarceva Radiant Investigator Grp

Adjuvant erlotinib (E) versus placebo (P) in non-small cell lung cancer (NSCLC) patients (pts) with tumors carrying EGFR-sensitizing mutations from the RADIANT trial

In: Journal of Clinical Oncology (JCO) Jg. 32 S (2014) Nr. 15, S. 7513

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
O'Brien, MER; Eberhardt, Wilfried; Altorki, N. K.; Spigel, D. R.; Crino, L.; Tsai, C. M.; Cho, E. K.; Kim, J. H.; Szczesna, A.; Hoffman, P. C.; Burghuber, O.; Keshavjee, S.; Orlov, S.; Serwatowski, P.; Wang, J. Z.; Foley, M. A.; Horan, J. D.; Park, J. W.; Shepherd, F. A.; Kelly, K.; Tarceva Radiant Investigator Grp

Analysis of treatment duration and safety of adjuvant erlotinib (E) versus placebo (P) after surgery in patients (pts) with non-small cell lung cancer (NSCLC) : RADIANT trial

In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 7535

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Christoph, Daniel; Reyna-Asuncion, Bernadette; Hassan, Biftu; Tran, Cindy; Maltzman, Julia D; O'Shannessy, Daniel J; Gauler, Thomas; Wohlschläger, Jeremias; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R

Assessment of Folate Receptor-α and Epidermal Growth Factor Receptor Expression in Pemetrexed-Treated Non–Small-Cell Lung Cancer Patients

In: Clinical Lung Cancer Jg. 15 (2014) Nr. 5, S. 320 - 330.e3

ISSN: 1525-7304; 1938-0690

Online Volltext: dx.doi.org/
Deppermann, Karl-Matthias; Hoffmann, Hans; Eberhardt, Wilfried

Benefits and Risks of Lung Cancer Screening

In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 3, S. 58 - 66

ISSN: 2296-5262

Online Volltext: dx.doi.org/
Gauler, Thomas; Espenhain, L.; Hoiczyk, M.; Nel, I.; Parr, A.; Roder, J.; Schuler, Martin; Eberhardt, Wilfried; Roder, H.; Hoffmann, Andreas-Claudius

Correlation of proteomics and first-line platinum-based chemotherapy in stage NSCLC in a large single-center cohort

In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl.,

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Veit, S.; Heinrich, V.; Welter, Stefan; Spengler, W.; Schmidberger, H.; Lutke-Brintrup, D.; Lehmann, Nils; Jöckel, Karl-Heinz; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried

Definitive Hyperfractionated Accelerated (AHF) Radiochemotherapy (CRT) Versus Neoadjuvant AHF-CRT and Surgery (S) for Patients (pts) With Operable Stage IIIA(N2)/Selected IIIB Non-small-Cell Lung Cancer (NSCLC) Following Induction Chemotherapy (IND-C) : Results From a Multicenter Phase III Study

In: International Journal of Radiation Oncology, Biology, Physics Jg. 90 (2014) Nr. 1 Suppl., S. S146 - S147

ISSN: 0360-3016

Online Volltext: dx.doi.org/
Nensa, Felix; Stattaus, Jörg; Morgan, Bruno; Horsfield, Mark A.; Soria, Jean-Charles; Besse, Benjamin; Gounant, Valerie; Khalil, Antoine; Seng, Katja; Fischer, Berthold; Krissel, Heiko; Laurent, Dirk; Christoph, Daniel; Eberhardt, Wilfried; Gauler, Thomas

Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer

In: Future Oncology Jg. 10 (2014) Nr. 5, S. 823 - 833

ISSN: 1744-8301; 1479-6694

Online Volltext: dx.doi.org/
Eberhardt, Wilfried; Mitchell, Paul; Schiller, Joan H.; Brown, Michael P.; Thomas, Michael; Mills, Glenn; Jehl, Valentine; Urva, Shveta R.; De Leo, Jeffrey J.; Gogov, Sven; Papadimitrakopoulou, Vasiliki

Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non-small cell lung cancer

In: Investigational New Drugs: The Journal of New Anticancer Agents Jg. 32 (2014) Nr. 1, S. 123 - 134

ISSN: 1573-0646

Online Volltext: dx.doi.org/
Kreuter, M.; Vansteenkiste, J.; Herth,~F.~J.~F.; Fischer, J. R.; Eberhardt, Wilfried; Zuna, I.; Reinmuth, N.; Griesinger, F.; Thomas, M.

Impact and safety of adjuvant chemotherapy on pulmonary function in early stage non-small cell lung cancer

In: Respiration: International Journal of Thoracic Medicine Jg. 87 (2014) Nr. 3, S. 204 - 210

ISSN: 1423-0356; 0025-7931; 0368-9220

Online Volltext: dx.doi.org/
Gkika, E.; Gauler, Thomas; Eberhardt, Wilfried; Stahl, Michael; Stuschke, Martin; Pöttgen, Christoph

Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus

In: Diseases of the Esophagus Jg. 27 (2014) Nr. 7, S. 678 - 684

ISSN: 1120-8694; 1442-2050

Online Volltext: dx.doi.org/
Sebastian, M; Niederle, Norbert; Thomas, M; Reck, M; Schmittel, A; Fischer, B; Overbeck, T; Gröschel, A; Deppermann, M; Pirker, R; Huber, R M; Eberhardt, Wilfried; Griesinger, F

Molekulargenetische Untersuchungen bei fortgeschrittenem nicht-kleinzelligem Lungenkarzinom : praktische Relevanz

In: Deutsche Medizinische Wochenschrift: DMW Jg. 139 (2014) Nr. 41, S. 2096 - 2100

ISSN: 1439-4413; 0012-0472

Online Volltext: dx.doi.org/
Leijen, S.; Barlesi, F.; Eberhardt, Wilfried; Martinez, G. M.; Dieras, V.; Schellens, JHM; Middleton, M.; Calvo, E.; Paz-Ares, L.; Larkin, J.; Jodrell, D.; Soria, J. C.

Ocular toxicities observed with MEK inhibitor RO4987655 (CH4987655) in a single agent phase I study with extension in patients with advanced solid tumors

In: British Journal of Clinical Pharmacology (BJCP) Jg. 78 (2014) Nr. 4, S. 769

ISSN: 0264-3774; 0306-5251

Online Volltext: dx.doi.org/
Sterzing, F.; Eberhardt, Wilfried; Friedel, G.; Pöttgen, Christoph; Rieken, S.

Oligometastasiertes Lungenkarzinom : Neue prognoserelevante Konzepte

In: Der Onkologe Jg. 20 (2014) Nr. 10, S. 991 - 997

ISSN: 1433-0415

Online Volltext: dx.doi.org/
Zimmer, Lisa; Barlesi, Fabrice; Martinez-Garcia, Maria; Dieras, Veronique; Schellens, Jan. H.M.; Spano, Jean-Phillipe; Middleton, Marc R.; Calvo, Emiliano; Paz-Ares, Luiz; Larkin, James; Pacey, Simon; Venturi, Miro; Kraeber-Bodéré, Francoise; Tessier, Jean J. L.; Eberhardt, Wilfried; Paques, Michel; Guarin, Ernesto; Meresse, Valerie; Soria, Jean-Charles

Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations

In: Clinical Cancer Research Jg. 20 (2014) Nr. 16, S. 4251 - 4261

ISSN: 1557-3265

Online Volltext: dx.doi.org/
Eberhardt, Wilfried; Gauler, Thomas; Pöttgen, Christoph; Friedel, G.; Veit, S.; Heinrich, V.; Welter, Stefan; Spengler, W.; Kimmich, M.; Fischer, B.; Schmidberger, H.; Gkika, E.; Cordes, S.; Hepp, R.; Luetke-Brintrup, D.; Lehmann, Nils; Schuler, Martin; Jöckel, Karl-Heinz; Stamatis, Georgios; Stuschke, Martin; ESPATUE AIO ARO Clinical Trials

Phase III study of surgery (S) versus definitive concurrent chemoradiotherapy boost (def ccCRTx-BOx) in patients (pts) with operable (OP+) stage IIIA(N2)/selected IIIb (sel IIIB) non-small cell lung cancer (NSCLC) following induction (IND) chemotherapy (CTx) and concurrent CRTx (ESPATUE)

In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. 7510

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Chalvatzoulis, E.; Wohlschläger, Jeremias; Hager, T.; Cheufou, D.; Eberhardt, Wilfried; Stamatis, Georgios; Welter, Stefan

Resection of a Giant Neuroblastoma Misdiagnosed as Atypical Mediastinal Carcinoid

In: Journal of Thoracic Oncology Jg. 9 (2014) Nr. 1, S. 132 - 134

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/
Christoph, Daniel; Eberhardt, Wilfried

Systemic treatment of malignant pleural mesothelioma: new agents in clinical trials raise hope of relevant improvements

In: Current Opinion in Oncology Jg. 26 (2014) Nr. 2, S. 171 - 181

ISSN: 1531-703X

Online Volltext: dx.doi.org/
Butts, C.; Socinski, M. A.; Mitchell, P. L.; Thatcher, N.; Havel, L.; Krzakowski, M.; Nawrocki, S.; Ciuleanu, T.-E.; Bosquée, L.; Trigo, J. M.; Spira, A.; Tremblay, L.; Nyman, J.; Ramlau, R.; Wickart-Johansson, G.; Ellis, P.; Gladkov, O.; Pereira, J. R.; Eberhardt, Wilfried; Helwig, C.; Schröder, A.; Shepherd, F. A.

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START) : A randomised, double-blind, phase 3 trial

In: The Lancet Oncology Jg. 15 (2014) Nr. 1, S. 59 - 68

ISSN: 1474-5488

Online Volltext: dx.doi.org/ (Open Access)
Eberhardt, Wilfried; Gauler, Thomas; Lepechoux, C.; Stamatis, Georgios; Bildat, Stephan; Krbek, T.; Welter, Stefan; Grunenwald, D.; Fischer, B.; Rodrigo, H. D.; Theegarten, Dirk; Le Chevalier, T.; Seeber, Siegfried; Stuschke, Martin; Pöttgen, Christoph

10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45 Gy (1.5 Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)—A multicenter phase-II trial (CISTAXOL)

In: Lung Cancer Jg. 82 (2013) Nr. 1, S. 83 - 89

ISSN: 0169-5002

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Eberhardt, Wilfried; Graupner, Britta; Theegarten, Dirk; Gauler, Thomas; Freitag, Lutz; Abu Jawad, Jehad; Wohlschläger, Jeremias; Welter, Stefan; Stamatis, Georgios; Stuschke, Martin

Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer : Markedly higher rate of pathologic complete remissions than with conventional fractionation

In: European Journal of Cancer Jg. 49 (2013) Nr. 9, S. 2107 - 2115

ISSN: 0959-8049; 1879-0852

Online Volltext: dx.doi.org/
Souquet, P. J.; Dietel, M.; Eberhardt, Wilfried; Fournel, P.; Von der Schulenburg, JMG; Locher, C.; Sabourin, J. C.; Schirmacher, P.; Thomas, M.; Schuette, W.

EGFR mutation and management of advanced non-small cell lung cancer (NSCLC) adenocarcinoma in Germany and France

In: European Journal of Cancer Jg. 49 (2013) Nr. Suppl. 2, S. 817

ISSN: 0959-8049

Online Volltext: dx.doi.org/
Ting, Saskia; Mairinger, Fabian D.; Hager, Thomas; Welter, Stefan; Eberhardt, Wilfried; Wohlschläger, Jeremias; Schmid, Kurt Werner; Christoph, Daniel

ERCC1, MLH1, MSH2, MSH6, and βiII-tubulin: Resistance proteins associated with response and outcome to platinum-based chemotherapy in malignant pleural mesothelioma

In: Clinical Lung Cancer Jg. 14 (2013) Nr. 5, S. 558 - 567

ISSN: 1938-0690; 1525-7304

Online Volltext: dx.doi.org/
Vansteenkiste, J.; De Ruysscher, D.; Eberhardt, Wilfried; Lim, E.; Senan, S.; Felip, E.; Peters, S.; ESMO Guidelines Working Grp

Early and locally advanced non-small-cell lung cancer (NSCLC) : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

In: Annals of Oncology Jg. 24 (2013) Nr. Suppl. 6, S. vi89 - vi98

ISSN: 0923-7534; 1569-8041

Online Volltext: dx.doi.org/
Hirsch, F. R.; Jänne, P. A.; Eberhardt, Wilfried; Cappuzzo, F.; Thatcher, N.; Pirker, R.; Choy, H.; Kim, E. S.; Paz-Ares, L.; Gandara, D. R.; Wu, Y. L.; Ahn, M. J.; Mitsudomi, T.; Shepherd, F. A.; Mok, T. S.

Epidermal Growth Factor Receptor Inhibition in Lung Cancer : Status 2012

In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. 3, S. 373 - 384

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/
Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, Karl; Kasper, Stefan; Tewes, Mitra; Welt, Anja; Richly, Heike; Meiler, Johannes; Bauer, Sebastian; Hense, Jörg; Gauler, Thomas; Köhler, Jens; Eberhardt, Wilfried; Darwiche, Kaid; Freitag, Lutz; Stamatis, Georgios; Breitenbücher, Frank; Wohlschläger, Jeremias; Theegarten, Dirk; Derks, Cordula; Cortes-Incio, Diana; Linden, Gabriele; Skottky, Silke; Lütkes, Peter; Dechene, Alexander; Paul, Andreas; Markus, Peter; Schmid, Kurt Werner; Schuler, Martin

Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center

In: European Journal of Cancer Jg. 49 (2013) Nr. 15, S. 3076 - 3082

ISSN: 0959-8049; 1879-0852

Online Volltext: dx.doi.org/
Nel, I.; Gauler, Thomas; Eberhardt, Wilfried; Nickel, A. C.; Schuler, Martin; Thomale, Jürgen; Hoffmann, Andreas-Claudius

Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatment

In: British Journal of Cancer (BJC) Jg. 109 (2013) Nr. 5, S. 1223 - 1229

ISSN: 1532-1827; 0007-0920

Online Volltext: dx.doi.org/ (Open Access)
Rebmann, Vera; Gauler, Thomas; Schott, B.; Schott, P.; Bauer, Sebastian; Opalka, Bertram; Stamatis, Georgios; Eberhardt, Wilfried; Schuler, Martin; Horn, Peter

Free soluble HLA-G molecules but not exosome-derived soluble HLA-G molecules are of prognostic relevance in lung cancer patients

In: Tissue Antigens Jg. 81 (2013) Nr. 5, S. 282 - 283

ISSN: 0001-2815; 1399-0039

Online Volltext: dx.doi.org/
Welter, Stefan; Schwan, Alexandra; Cheufou, Danjouma; Darwiche, Kaid; Christoph, Daniel; Eberhardt, Wilfried; Weinreich, Gerhard; Stamatis, Georgios

Midterm changes in quality of life : A prospective evaluation after open pulmonary metastasectomy

In: The Annals of Thoracic Surgery Jg. 95 (2013) Nr. 3, S. 1006 - 1011

ISSN: 0003-4975; 1552-6259

Online Volltext: dx.doi.org/
Eberhardt, Wilfried; Gauler, Thomas; Schadendorf, Dirk

Neue Entwicklungen in der Behandlung von soliden Tumoren mit zielgerichteten Medikamenten. Lunge, Niere, Melanom

In: Der Onkologe Jg. 19 (2013) Nr. 10, S. 821 - 834

ISSN: 1433-0415

Online Volltext: dx.doi.org/
Dumitru, Claudia A.; Bankfalvi, Agnes; Gu, Xiang; Eberhardt, Wilfried; Zeidler, Reinhard; Lang, Stephan; Brandau, Sven

Neutrophils activate tumoral CORTACTIN to enhance progression of orohypopharynx carcinoma

In: Frontiers in Immunology Jg. 4 (2013) S. 33

ISSN: 1664-3224

Online Volltext: dx.doi.org/ (Open Access)
Knoedler, M.; Gauler, Thomas; Gruenwald, V.; Matzdorff, A.; Schroeder, M.; Dietz, A.; Jordan, W. O.; Arnold, D.; Hennemann, B.; Hofele, C.; Weissinger, F.; Eberhardt, Wilfried; Keilholz, U.

Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy : A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie

In: Oncology Jg. 84 (2013) Nr. 5, S. 284 - 289

ISSN: 0030-2414; 1423-0232

Online Volltext: dx.doi.org/
Gauler, Thomas; Besse, B.; Novello, S.; Smit, E. F.; Plummer, E. R.; Delord, J. P.; Nicodemo, M.; Santoro, A.; Barone, C.; Marchetti, P.; Conte, P. F.; De Jonge, M. J.; Awada, A.; Mariani, M.; Jannuzzo, M. G.; Petroccione, A.; Ceruti, R.; Davite, C.; Eberhardt, Wilfried

Phase II study of danusertib (D) in advanced/metastatic non-small cell lung cancers (NSCLC)

In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 15 Suppl., S. e19138

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Gauler, Thomas Christoph; Christoph, Daniel Christian; Fischer, Juergen; Frickhofen, Norbert; Huber, Rudolf; Gonschorek, Christine; Roth, Katrin; Giurescu, Marius; Eberhardt, Wilfried Ernst Erich

Phase-I study of sagopilone in combination with cisplatin in chemotherapy-naive patients with metastasised small-cell lung cancer

In: European journal of cancer Jg. 49 (2013) Nr. 11, S. 2461 - 2468

ISSN: 0959-8049; 1879-0852

Online Volltext: dx.doi.org/
Kreuter, Michael; Vansteenkiste, Johan F.; Fischer, Jürgen Richard; Eberhardt, Wilfried; Zabeck, Heike; Kollmeier, Jens; Serke, Monika; Frickhofen, Norbert; Reck, Martin P.; Engel-Riedel, Walburga; Neumann, Silke; Thomeer, Michiel J.; Schumann, Christian; De Leyn, Paul De J.; Graeter, Thomas P.; Stamatis, Georgios; Zuna, Ivan; Griesinger, Frank; Thomas, Michael N.

Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine : The TREAT study

In: Annals of Oncology Jg. 24 (2013) Nr. 4, S. 986 - 992

ISSN: 1569-8041; 0923-7534

Online Volltext: dx.doi.org/
Christoph, Daniel; Reyna-Asuncion, Bernadette; Hassan, Biftu; Tran, Cindy; Maltzman, Julia D.; O'Shannessy, Daniel J.; Wynes, Murry W.; Gauler, Thomas; Wohlschläger, Jeremias; Hoiczyk, M.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.

Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed

In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. 1, S. 19 - 30

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/
Stahel, R.; Peters, S.; Baas, P.; Brambilla, E.; Cappuzzo, F.; De Ruysscher, D.; Eberhardt, Wilfried; Felip, E.; Fennell, D.; Marchetti, A.; Paz-Ares, L.; Adjei, A. A.

Strategies for improving outcomes in NSCLC : A look to the future

In: Lung Cancer Jg. 82 (2013) Nr. 3, S. 375 - 382

ISSN: 0169-5002

Online Volltext: dx.doi.org/
Tufman, Amanda; Schumann, Christian; Huber, Rudolf M.; Eberhardt, Wilfried; Flentje, Michael; Haug, Alexander; Junker, Klaus; Pfluger, Thomas; Winter, Hauke

Tumorkonferenz II

In: Onkologie Jg. 36 (2013) Nr. 6, S. 14 - 16

ISSN: 1423-0240; 0378-584X

Online Volltext: dx.doi.org/
Vansteenkiste, J. F.; Paz-Ares, L.; Eisen, TQG; Heigener, D.; Eberhardt, Wilfried; Thomas, M.; Zhou, C.; Santoro, A.; Lathia, C.; Roder, H.

A plasma proteomic signature predicts outcomes in a phase 3 study of Gemcitabine (G) plus Cisplatin (C) +/- sorafenib in first line stage IIIB or IV NSCLC

In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 407

ISSN: 0923-7534; 1569-8041
Christoph, Daniel; Hoffmann, Andreas-Claudius; Gauler, Thomas; Asuncion, Bernadette Reyna; Loewendick, Heike; Peglow, Anja; Hassan, Biftu; Tran, Cindy; Wynes, Murry W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.

Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexed

In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 4, S. 766 - 767

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Drescher, O.; Eberhardt, Wilfried; Prittwitz, R.; Gkika, E.; Korfee, Sönke; Theegarten, Dirk; Welter, Stefan; Krbek, T.; Stamatis, Georgios; Pöttgen, Christoph; Schuler, Martin; Christoph, Daniel

Distribution pattern of metastases and their associations with survival of malignant pleural mesothelioma patients undergoing different treatment modalities

In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 140

ISSN: 0378-584X; 1423-0240
Pirker, Robert; Pereira, Jose R; Von Pawel, Joachim; Krzakowski, Maciej; Ramlau, Rodryg; Park, Keunchil; De Marinis, Filippo; Eberhardt, Wilfried; Paz-Ares, Luis; Störkel, Stephan; Schumacher, Karl-Maria; Von Heydebreck, Anja; Celik, Ilhan; O'Byrne, Kenneth J

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer : analysis of data from the phase 3 FLEX study

In: The Lancet Oncology Jg. 13 (2012) Nr. 1, S. 33 - 42

ISSN: 1470-2045; 1474-5488

Online Volltext: dx.doi.org/
Schuette, W.; Eberhardt, Wilfried; von der Schulenburg, JMG; Dietel, M.; Schirmacher, P.; Zaun, S.; Thomas, M.

EGFR mutation analysis from REASON : A registry for the epidemiologic and scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV

In: Journal of Clinical Oncology Jg. 30 (2012) Nr. Suppl. 15, S. e18016

ISSN: 0732-183X; 1527-7755
Schuette, W.; Eberhardt, Wilfried; von der Schulenburg, JMG; Dietel, M.; Schirmacher, P.; Fischer, J. R.; Mezger, J.; Schumann, C.; Serke, M.; Zaun, S.; Thomas, M.

EGFR mutation analysis from the German REASON study - a registry for the epidemiologic and scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV

In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 36

ISSN: 0378-584X; 1423-0240
Pöttgen, Christoph; Levegrün, Sabine; Abu Jawad, Jehad; Lübcke, Wolfgang; Gkika, E.; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin

Effektivität und Toxizität von bildgeführter hochkonformaler Bestrahlung multipler zerebraler Metastasen mit/ohne Ganzhirnbestrahlung (WBRT) mittels helikaler Tomotherapie

In: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. 1 Suppl., S. 41 - 42

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Kohlhaufl, M.; Hehr, T.; Budach, W.; Bamberg, M.; Welter, Stefan; Stamatis, Georgios; Fischer, B.; Eberhardt, Wilfried

Erste Sicherheitsanalyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie : Keine Signale für unerwartete Adverse Events/Toxizitäten

In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 188 (2012) Nr. Suppl. 1, S. 34

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Christoph, Daniel; Asuncion, Bernadette Reyna; Mascaux, Celine; Tran, Cindy; Lu, Xian; Wynes, Murry W.; Gauler, Thomas; Wohlschläger, Jeremias; Theegarten, Dirk; Neumann, Volker; Hepp, Rodrigo; Welter, Stefan; Stamatis, Georgios; Tannapfel, Andrea; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.

Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma

In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, S. 1440 - 1448

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Eberhardt, Wilfried; Griesinger, Frank; Filipits, Martin; Winter, Hauke

Frühes Stadium beim nichtkleinzelligen Lungenkarzinom

In: Onkologie Jg. 35 (2012) Nr. Suppl. 3, S. 6 - 9

ISSN: 0378-584X; 1423-0240

Online Volltext: dx.doi.org/
Welter, Stefan; Grabellus, Florian; Bauer, Sebastian; Schuler, Martin; Eberhardt, Wilfried; Tötsch, M.; Stamatis, Georgios

Growth patterns of lung metastases from sarcoma : prognostic and surgical implications from histology

In: Interactive Cardiovascular and Thoracic Surgery Jg. 15 (2012) Nr. 4, S. 612 - 617

ISSN: 1569-9285; 1569-9293

Online Volltext: dx.doi.org/
Kohler, J.; Worm, K.; Gauler, Thomas; Hoiczyk, M.; Theegarten, Dirk; Eberhardt, Wilfried; Hense, Jörg; Breitenbücher, Frank; Schmid, Kurt Werner; Schuler, Martin

Impact of EGFR mutation status on clinical benefit from BIBW 2992 in patients (PTS) with advanced non-small lung cancer (NSCLC) progressing after chemotherapy (CTX) and erlotinib (E) or gefitinib (G) - a single center experience

In: Annals of Oncology Jg. 23 (2012) Nr. Suppl. 9, S. 437 - 438

ISSN: 0923-7534; 1569-8041
Pöttgen, Christoph; Graupner, B.; Abu Jawad, Jehad; Gauler, Thomas; Theegarten, Dirk; Wohlschläger, Jeremias; Freitag, Lutz; Welter, Stefan; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin

Improvement of histopathological Remission after neoadjuvant chemotherapy of accelerated hyperfractionation compared to conventional fractionation in locally advanced NSCLC (stage III)

In: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. Suppl. 1, S. 96 - 96

ISSN: 0179-7158; 1439-099X
Sak, Ali; Groneberg, M.; Pöttgen, Christoph; Kuebler, D.; Eberhardt, Wilfried; Stuschke, Martin

Increased effect of Aurora-B kinase inhibition on endoreplicated non-small lung cancer cell lines

In: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. 1 Suppl., S. 115

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Sak, Ali; Stuschke, Martin; Groneberg, Michael; Kübler, Dennis; Pöttgen, Christoph; Eberhardt, Wilfried

Inhibiting the aurora B kinase potently suppresses repopulation during fractionated irradiation of human lung cancer cell lines

In: International Journal of Radiation Oncology Biology Physics Jg. 84 (2012) Nr. 2, S. 492 - 499

ISSN: 0360-3016; 1879-355X

Online Volltext: dx.doi.org/
Christoph, Daniel; Asuncion, B. R.; Hassan, B.; Maltzman, J.; O'Shannessy, D.; Gauler, Thomas; Wynes, M. W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.

Investigation of Folate Receptor alpha and Thymidylate Synthase Proteins Expression in metastatic Non-Small Cell Lung Cancer Patients treated with Pemetrexed-based Chemotherapy

In: Journal of Thoracic Oncology Jg. 7 (2012) Nr. 9, Suppl. 4, S. S211 - S212

ISSN: 1556-0864; 1556-1380
Leijen, Suzanne; Middleton, Mark R.; Tresca, Patricia; Kraeber-Bodéré, Françoise; Dieras, Veronique; Scheulen, Max Ernst; Gupta, Avinash; Lopez-Valverde, Vanesa; Xu, Zhi-Xin; Rueger, Ruediger; Tessier, Jean J. L.; Shochat, Eliezer; Blotner, Steve; Naegelen, Valerie Meresse; Schellens, Jan H. M.; Eberhardt, Wilfried

Phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of the MEK inhibitor RO4987655 (CH4987655) in patients with advanced solid tumors

In: Clinical Cancer Research Jg. 18 (2012) Nr. 17, S. 4794 - 4805

ISSN: 1078-0432; 1557-3265

Online Volltext: dx.doi.org/ (Open Access)
Gauler, Thomas; Besse, Benjamin; Mauguen, Audrey; Méric, Jean Baptiste; Gounant, Valérie; Fischer, Berthold M.; Overbeck, Tobias R.; Krissel, Heiko; Laurent, Dirk; Tiainen, Marianne; Commo, Frédéric; Soria, Jean-Charles; Eberhardt, Wilfried

Phase II trial of ptk787/zk 222584 (vatalanib) administered orally once-daily or in two divided daily doses as second-line monotherapy in relapsed or progressing patients with stage iiib/iv non-small-cell lung cancer (nsclc)

In: Annals of Oncology Jg. 23 (2012) Nr. 3, S. 678 - 687

ISSN: 1569-8041

Online Volltext: dx.doi.org/
Trarbach, Tanja; Schultheis, Beate; Gauler, Thomas; Schneider, Vesile; Strumberg, Dirk; Eberhardt, Wilfried; Le Scouiller, Stephanie; Marotti, Marcelo; Brown, Kathryn H.; Drevs, Joachim

Phase i open-label study of cediranib, an oral inhibitor of VEGF signalling, in combination with the oral Src inhibitor saracatinib in patients with advanced solid tumours

In: Investigational New Drugs: The Journal of New Anticancer Agents Jg. 30 (2012) Nr. 5, S. 1962 - 1971

ISSN: 0167-6997; 1573-0646

Online Volltext: dx.doi.org/
Pirker, R.; Pereira, J.R.; Szczesna, A.; von Pawel, J.; Krzakowski, M.; Ramlau, R.; Vynnychenko, I.; Park, K.; Eberhardt, Wilfried; de Marinis, F.; Heeger, S.; Goddemeier, T.; O'Byrne, K.J.; Gatzemeier, U.

Prognostic factors in patients with advanced non-small cell lung cancer : Data from the phase III FLEX study

In: Lung Cancer Jg. 77 (2012) Nr. 2, S. 376 - 382

ISSN: 0169-5002; 1872-8332

Online Volltext: dx.doi.org/
Christoph, Daniel; Asuncion, B. R.; Hassan, B.; Maltzman, J.; O'Shannessy, D.; Gauler, Thomas; Wohlschläger, Jeremias; Wynes, M. W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.

Significance of Folate Receptor alpha (FRA) and Thymidylate Synthase (TS) expression in metastatic non-small cell lung cancer patients treated with pemetrexed-based chemotherapy

In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 34

ISSN: 0378-584X; 1423-0240
Gottschling, Sandra; Herpel, Esther; Eberhardt, Wilfried; Heigener, David F.; Fischer, Jürgen R.; Köhne, Claus-Henning; Kortsik, Cornelius; Kuhnt, Thomas; Muley, Thomas; Meister, Michael; Bischoff, Helge G.; Klein, Peter; Moldenhauer, Ines; Schnabel, Philipp A.; Thomas, Michael; Penzel, Roland

The gefitinib long-term responder (LTR) : a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)

In: Lung Cancer Jg. 77 (2012) Nr. 1, S. 183 - 191

ISSN: 1872-8332; 0169-5002

Online Volltext: dx.doi.org/
Wiesweg, Marcel; Kasper, Stefan; Wohlschläger, Jeremias; Ting, Saskia; Skottky, S.; Worm, K.; Derks, C.; Tewes, Mitra; Breitenbücher, Frank; Gauler, Thomas; Eberhardt, Wilfried; Ahrens, M.; Hoiczyk, M.; Meiler, Johannes; Hense, Jörg; Welt, Anja; Theegarten, Dirk; Freitag, Lutz; Kimmig, Rainer; Schmid, Kurt Werner; Schuler, Martin

VVTZ-Tumorprofil - First results of a preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center

In: Onkologie Jg. 35 (2012) Nr. Suppl. 6, S. 204 - 204

ISSN: 0378-584X; 1423-0240
Christoph, Daniel; Kasper, Stefan; Gauler, Thomas; Loesch, Christian; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Welter, Stefan; Stamatis, Georgios; Hirsch, Fred R.; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias

Βv-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer

In: British Journal of Cancer (BJC) Jg. 107 (2012) Nr. 5, S. 823 - 830

ISSN: 1532-1827; 0007-0920

Online Volltext: dx.doi.org/ (Open Access)
Heusner, Till Alexander; Gölitz, Philipp; Hamami, Monia; Eberhardt, Wilfried; Esser, Stefan; Forsting, Michael; Bockisch, Andreas; Antoch, Gerald

"One-stop-shop" staging : should we prefer FDG-PET/CT or MRI for the detection of bone metastases?

In: European Journal of Radiology Jg. 78 (2011) Nr. 3, S. 430 - 435

ISSN: 0720-048X; 1872-7727

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Le Pechoux, C.; Gauler, Thomas; Stuschke, Martin; Grunenwald, D. H.; Stamatis, Georgios; Bildat, Stephan; Krbek, T.; Christoph, Daniel; Welter, Stefan; Fischer, B.; Hepp, R.; Theegarten, Dirk; Eberhardt, Wilfried

10-year long-term survival (LTS) of induction (IND) chemotherapy (CTX) with three cycles cisplatin(P)/paclitaxel(T) followed by concurrent (CC) chemoradiation (CTX/RTX) P/Etoposide (ETO)/45 GY (1.5 GY BID) plus surgery (S) - A multicenter phase-II trial (Cistaxol)

In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. 494

ISSN: 1556-0864; 1556-1380
Hepp, R.; Gauler, Thomas; Pöttgen, Christoph; Korfee, Sönke; Bildat, Stephan; Stamatis, Georgios; Seeber, S.; Wilke, Hansjochen; Budach, V.; Stuschke, Martin; Eberhardt, Wilfried

15-Year (very) long-term survival (VLTS) and competing risks (CR) analysis of induction (IND) chemotherapy (CTX) with three cycles cisplatin (P) / etoposide (E) followed by concurrent (CC) chemoradiation (CTX/RTX) PE/45 GY (1.5 GY BID) pkus surgery (S) = TRIM

In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S.S 492 - S493

ISSN: 1556-0864; 1556-1380
Schmittel, Alexander; Sebastian, Martin; Fischer von Weikersthal, Ludwig; Martus, Peter; Gauler, Thomas; Kaufmann, Caroline; Hortig, Patricia; Fischer, Jürgen Richard; Link, Hartmut; Binder, Daniel; Fischer, Berthold; Caca, Karel; Eberhardt, Wilfried; Keilholz, Ulrich

A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer

In: Annals of Oncology Jg. 22 (2011) Nr. 8, S. 1798 - 1804

ISSN: 0923-7534; 1569-8041

Online Volltext: dx.doi.org/ (Open Access)
Deutschbein, T.; Unger, Nicole; Yüce, Ali; Eberhardt, Wilfried; Gauler, Thomas; Lahner, Harald; Mann, Klaus; Petersenn, Stephan

Chemotherapy in Patients with Progressive, Undifferentiated Neuroendocrine Tumors : A Single-Center Experience

In: Hormone and Metabolic Research Jg. 43 (2011) Nr. 12, S. 838 - 843

ISSN: 1439-4286

Online Volltext: dx.doi.org/
Eberhardt, Wilfried; Stuschke, Martin

Combined modality treatment, especially concomitant chemoradiation : Which chemotherapy? Which Radiotherapy fractionation scheme?Toxicities?

In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. S214 - S215

ISSN: 1556-0864; 1556-1380
Eberhardt, Wilfried; Hepp, R.; Gauler, Thomas; Christoph, Daniel; Hoffmann, Andreas-Claudius; Theegarten, Dirk; Welter, Stefan; Schmid, Kurt Werner; Wohlschläger, Jeremias; Passlick, B.; Le Pechoux, C.; Stamatis, Georgios; Stuschke, Martin; Pöttgen, Christoph

Competing risks analysis and long-term survival (LTS) of patients (PTS) with locally advanced (LAD) stage III non-small- cell lung cancer (NSCLC) treated on sequential trimodality (TM) trials

In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. S376 - S377

ISSN: 1556-0864; 1556-1380
Gauler, Thomas; Theegarten, Dirk; Parr, A.; Schuhr, I.; Schmid, Kurt Werner; Eberhardt, Wilfried; Schuler, Martin; Hoffmann, Andreas-Claudius

Decrease of circulating tumor cells associates with response to platinum-based chemotherapy in patients with non-small cell lung cancer, but not with small cell lung cancer

In: J Thorac Oncol Jg. 6 (2011) Nr. Suppl. 6, S. 1114

ISSN: 1556-0864; 1556-1380
Thomas, M.; Eberhardt, Wilfried; Graf von der Schulenburg, J.M.; Dietel, M.; Schumacher, P.; Gutendorf, B.; Zirrgiebel, U.; Schütte, W.

EGFR Mutation Status in NSCLC Patients Stage IIIB/IV in Germany -Initial Results From a German Registry

In: European Journal of Cancer Jg. 47 (2011) Nr. Suppl. 1, S. S596

ISSN: 0959-8049

Online Volltext: dx.doi.org/
Eberhardt, Wilfried; Senan, S.; Weder, W.; Faivre-Finn, C.; Vansteenkiste, J.

Early and locally advanced disease

In: Lung Cancer Jg. 71 (2011) Nr. Suppl. 2, S. 2

ISSN: 0169-5002

Online Volltext: dx.doi.org/
Sak, Ali; Stuschke, Martin; Groneberg, M.; Pöttgen, Christoph; Kubler, D.; Eberhardt, Wilfried

Effect of Aurora-B kinase inhibition on radiation induced cell-cycle checkpoint activation and cell death in non-small lung cancer cell lines

In: Strahlentherapie und Onkologie Jg. 187 (2011) Nr. Suppl. 1, S. 123

ISSN: 0179-7158; 1439-099X
Christoph, DanielC; Kasper, Stefan; Gauler, ThomasC; Breitenbücher, Frank; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Hirsch, FredR; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias

Evaluation of Betav-Tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer

In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. 1078

ISSN: 1556-0864; 1556-1380
Christoph, Daniel; Gauler, Thomas; Engelhard, M.; Theegarten, Dirk; Pöttgen, Christoph; Hepp, R.; Schuler, Martin; Hirsch, F.; Eberhardt, Wilfried; Wohlschläger, Jeremias

Evaluation of betaV-tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer (NSCLC)

In: European Journal of Cancer Jg. 47 (2011) Nr. Suppl. 4, S. 14

ISSN: 0959-8049
Gatzemeier, Ulrich; von Pawel, Joachim; Vynnychenko, Ihor; Zatloukal, Petr; de Marinis, Filippo; Eberhardt, Wilfried; Paz-Ares, Luis; Schumacher, Karl-Maria; Goddemeier, Thomas; O'Byrne, Kenneth J; Pirker, Robert

First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy : A subgroup analysis of data from the FLEX phase 3 study

In: The Lancet Oncology Jg. 12 (2011) Nr. 1, S. 30 - 37

ISSN: 1470-2045

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Levegrun, S.; Abu Jawad, Jehad; Wittig, Andrea; Hepp, R.; Gkika, E.; Grannaß, Andreas; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin

Hypofractionated image-guided radiotherapy (HF-IGRT) cerebral metastases by means of helical Tomotherapy

In: Strahlentherapie und Onkologie Jg. 187 (2011) Nr. Suppl. 1, S. 19 - 19

ISSN: 0179-7158; 1439-099X
Christoph, DanielC; Wohlschläger, Jeremias; Neumann, Volker; Gauler, ThomasC; Pöttgen, Christoph; Peglow, Anja; Tannapfel, Andrea; Schuler, Martin; Hirsch, FredR; Eberhardt, Wilfried; Theegarten, Dirk

Impact of dihydrofolate reductase expression for clinical benefit from pemetrexed in malignant pleural mesothelioma

In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S1052 - S1053

ISSN: 1556-0864; 1556-1380
Gauler, Thomas; Pöttgen, Christoph; Wagner, H.; Korfee, Sönke; Hepp, R.; Stamatis, Georgios; Pawel, J. von; Passlick, B.; Budach, V.; Wilke, Hansjochen; Seeber, S.; Stuschke, Martin; Eberhardt, Wilfried

Long-term survival (LTS) and competing risks within a prospective multi center German randomized trial comparing induction chemotherapy (CTx) followed by concurrent (cc) chemoradiation (CTx/RTx) plus surgery (SURG; TRIMODALITY) supplemented by PCI versus local treatment (Tx) alone (SURG + RTx) in operable IIIA NSCLC.

In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7042

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Gauler, Thomas; Pöttgen, Christoph; Korfee, Sönke; Wagner, H.; Hepp, R.; Stamatis, Georgios; Christoph, Daniel; Passlick, B.; Budach, V.; Seeber, S.; Wilke, Hansjochen; Stuschke, Martin; Eberhardt, Wilfried

Long-term survival (LTS) and competing risks within a prospective multicenter german randomized trial comparing induction (IND) chemotherapy (CTX) followed by concurrent (CC) chemoradiation (CTX/RTX) plus surgery (S) (= Trimodality) supplemented by PCI VE

In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. 495

ISSN: 1556-0864; 1556-1380
Eberhardt, Wilfried; Gauler, Thomas; Le Pechoux, C.; Hepp, R.; Welter, Stefan; Fischer, B.; Bildat, Stephan; Grunenwald, D.; Stamatis, Georgios; Stuschke, Martin; Pöttgen, Christoph

Long-term survival (S) of induction chemotherapy (CTx) with three cycles cisplatin (cis)/paclitaxel (pac) followed by concurrent (cc) chemoradiation (CTx/RTx) cis/etoposide (eto) and 45 Gy (1.5 Gy bid) plus surgery (SURG) : Phase II results (CISTAXOL)

In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7047

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Hepp, R.; Pöttgen, Christoph; Gauler, Thomas; Erichsen, Patricia; Le Pechoux, C.; Grunenwald, D.; Welter, Stefan; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried

Long-term survival results and prognostic factor analysis of two consecutive trimodality Phase-II trials in stage IIIA(N2) and selected stage IIIB non-small-cell lung cancer (NSCLC)

In: Strahlentherapie und Onkologie Jg. 187 (2011) Nr. Suppl. 1, S. 68 - 69

ISSN: 0179-7158; 1439-099X
Therasse, P.; Vansteenkiste, J. F.; Zielinski, M.; Pas, T. M. de; Atanackovic, D.; Sequist, L. V.; Vallieres, E.; Swisher, S.; Adams, S.; Passlick, B.; Eberhardt, Wilfried; Grunenwald, D.; Mok, T.; Boyer, M.; Katz, A.; Douillard, J.; Debois, M.; Brichard, V. G.; Altorki, N. K.

MAGRIT phase III trial : MAGE-A3 antigen-specific cancer immunotherapy (ASCI) as adjuvant therapy in patients with completely resected stage IB-IIIA NSCLC

In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. TPS210

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Eberhardt, Wilfried; Gauler, Thomas; Welter, Stefan; Krbek, Thomas; Stuschke, Martin; Pöttgen, Christoph

Multimodale Therapie des lokal-fortgeschrittenen nichtkleinzelligen Lungenkarzinoms

In: Der Onkologe Jg. 17 (2011) Nr. 8, S. 691 - 701

ISSN: 0947-8965; 1433-0415

Online Volltext: dx.doi.org/
Leijen, S.; Middleton, M. R.; Tresca, P.; Kraeber-Bodere, F.; Dieras, V.; Scheulen, Max Ernst; Tessier, J.; Xu, Z. X.; Shochat, E.; Walz, A.; Deutsch, J.; Blotner, S.; Lopez Valverde, V.; Naegelen, V. M.; Schellens, J. H. M.; Eberhardt, Wilfried

Phase I (Ph) safety, pharmacodynamic (PD), and pharmacokinetic (PK) trial of a pure MEK inhibitor (i), RO4987655, in patients with advanced /metastatic solid tumor

In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 3017

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Christoph, DanielC; Mascaux, Celine; Wynes, MurryW; Asuncion, Bernadette; Wohlschläger, Jeremias; Theegarten, Dirk; Gauler, Thomas; Neumann, Volker; Pöttgen, Christoph; Tran, Cindy; Tannapfel, Andrea; Schuler, Martin; Eberhardt, Wilfried; Hirsch, FredR

Predictive value of thymidylate synthase and Folypoly-Glutamate Synthease for clinical benefit from pemetrexed in malignant pleural mesothelioma

In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S1092 - S1093

ISSN: 1556-0864; 1556-1380
Christoph, Daniel; Mascaux, C.; Wynes, M. W.; Reyna Asuncion, B.; Wohlschläger, Jeremias; Theegarten, Dirk; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.

Predictive value of thymidylate synthase and folylpoly-glutamate synthetase for clinical benefit from pemetrexed in malignant pleural mesothelioma

In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7024

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Goeckenjan, G.; Sitter, Helmut; Thomas, Michael; Branscheid, Detlev; Flentje, Michael; Griesinger, Frank; Niederle, N.; Stuschke, Martin; Blum, Torsten; Deppermann, Karl-Matthias; Ficker, Joachim H.; Freitag, Lutz; Lübbe, Andreas Stephan; Reinhold, Thomas; Späth-Schwalbe, Ernst; Ukena, Dieter; Wickert, Martin; Wolf, M.; Andreas, Stefan; Auberger, Thomas; Baum, Richard Paul; Baysal, B.; Beuth, Joseph; Bickeböller, Heike; Böcking, Alfred; Bohle, Rainer Maria; Brüske, Irene; Burghuber, Otto; Dickgreber, Nicolas; Diederich, Stefan; Dienemann, Hendrick; Eberhardt, Wilfried; Eggeling, Stephan; Fink, Thomas; Fischer, Berthold; Franke, M.; Friedel, Godehard; Gauler, Thomas; Gütz, Sylvia; Hautmann, Hubert; Hellmann, Andreas; Hellwig, Dirk; Herth, Felix; Heußel, Claus Peter; Hilbe, Wolfgang; Hoffmeyer, Frank; Horneber, Markus; Huber, Rudolf Maria; Hübner, Jutta; Kauczor, Hans Ulrich; Kirchbacher, Klaus; Kirsten, Detlef; Kraus, Thomas; Lang, Susanne Maria; Martens, Uwe Marc; Mohn-Staudner, Andrea; Müller, Klaus Michael; Müller-Nordhorn, Jacqueline; Nowak, Dennis Alexander; Ochmann, Uta; Passlick, Bernward; Petersen, Iver; Pirker, Robert; Pokrajac, Boris; Reck, Martin; Riha, Susanne; Rübe, Christian; Schmittel, Alexander; Schönfeld, Nicolas; Schütte, Wolfgang; Serke, Monika; Stamatis, Georgios; Steingräber, Maria; Steins, Martin; Stoelben, Erich; Swoboda, Lothar; Teschler, Helmut; Tessen, Hans Werner; Weber, Matthias; Werner, Andreas; Wichmann, H.-E.; Irlinger Wimmer, E.; Witt, Christian; Worth, Heinrich

Prevention, diagnosis, therapy, and follow-up of lung cancer : interdisciplinary guideline of the German respiratory society and the German cancer society abridged version

In: Pneumologie Jg. 65 (2011) Nr. 8, S. e51 - e75

ISSN: 0934-8387; 1438-8790

Online Volltext: dx.doi.org/
Ramalingam, S.; Spigel, D.; Steins, M.; Engelman, J.; Novello, S.; Eberhardt, Wilfried; Schneider, C.; Crino, L.; Janne, P. A.; Liu, L.; Chen, D.; Brownstein, C.; Reck, M.

R1507, a monoclonal antibody to insulin-like growth factor receptor-1A (IGF-1R), in combination with erlotinib for advanced stage non-small cell lung cancer (NSCLC) : A placebo-controlled, randomized phase II study

In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. 6, Suppl. 2, S. 605

ISSN: 1556-0864; 1556-1380
Ramalingam, Suresh S.; Spigel, David R.; Chen, David; Steins, Martin B.; Engelman, Jeffrey A.; Schneider, Claus-Peter; Novello, Silvia; Eberhardt, Wilfried; Crino, Lucio; Habben, Kai; Liu, Lian; Jänne, Pasi A.; Brownstein, Carrie M.; Reck, Martin

Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung Cancer

In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 34, S. 4574 - 4580

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Hirsh, Vera; Paz-Ares, Luis; Boyer, Michael; Rosell, Rafael; Middleton, Gary; Eberhardt, Wilfried; Szczesna, Aleksandra; Reiterer, Pavel; Saleh, Mansoor; Arrieta, Oscar; Bajetta, Emilio; Webb, Roy T.; Raats, Johannes; Benner, Rebecca J.; Fowst, Camilla; Meech, Sandra J.; Readett, David; Schiller, Joan H.

Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 19, S. 2667 - 2674

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Kreuter, M.; Vansteenkiste, J. F.; Fischer, J. R.; Eberhardt, Wilfried; Zabeck, H.; Kollmeier, Hans-Joachim; Serke, M. H.; Frickhofen, N.; Reck, M.; Engel-Riedel, W.; Neumann, S.; Thomeer, M.; Schumann, C.; Deleyn, P.; Graeter, T.; Stamatis, Georgios; Zuna, I.; Griesinger, F.; Thomas, M.

Randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed (CPx) versus cisplatin and vinorelbine (CVb) : TREAT

In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15_suppl, S. 7002

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Ramalingam, S. S.; Spigel, D. R.; Steins, M.; Engelman, J. A.; Schneider, C.; Novello, S.; Eberhardt, Wilfried; Crino, L.; Janne, P. A.; Liu, L.; Brownstein, C. M.; Reck, M.

Randomized, double-blind, phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor receptor-1 (IGF-1R), for advanced-stage non-small cell lung cancer (NSCLC)

In: Journal of Clinical Oncology Jg. 29 (2011) Nr. Suppl. 15, -

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Thomas, M.; Eberhardt, Wilfried; von der Schulenburg, JMG; Dietel, M.; Schirmacher, P.; Gutendorf, B.; Schaller, F.; Schutte, W.

Reason : TKI sensitive EGFR mutation status and associated characteristics of advanced NSCLC patients - Results from a German registry

In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 124 - 125

ISSN: 0378-584X; 1423-0240
Schuette, W.; Eberhardt, Wilfried; Von Der Schulenburg, JMG; Dietel, M.; Schirmacher, P.; Gutendorf, B.; Thomas, M.

Reason : a registry for the epidemiologic and scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV in Germany

In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. 1244

ISSN: 1556-0864; 1556-1380
Krzakowski, M.; Heeger, S.; Pereira, J.R.; Paz-Ares, L.; von Pawel, J.; Schnaars, Y.; Eberhardt, Wilfried; Pirker, R.; Goddemeier, T.; Park, K.

Safety Analysis of Patient Subgroups Defined by Low and High Tumour Epidermal Growth Factor Receptor (EGFR) Expression in FLEX Study Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving Chemotherapy With or Without Cetuximab as First-Line Therapy

In: European Journal of Cancer Jg. 47 (2011) Nr. Suppl. 1, S. S598

ISSN: 0959-8049

Online Volltext: dx.doi.org/
Gottschling, S.; Herpel, E.; Eberhardt, Wilfried; Gatzemeier, U.; Fischer, J. R.; Köhne, C. H.; Kortsik, C.; Kuhnt, T.; Muley, T.; Meister, M.; Bischoff, H.; Schnabel, P. A.; Penzel, R.; Thomas, M.

The Gefitinib Long-Term Responder (LTR) - a cancer stem-like cell story? : Insights from molecular analyses of German long-term responders treated in the iressa expanded access program

In: Journal of Thoracic Oncology Jg. 6 (2011) Nr. Suppl. 6, S. S966 - S967

ISSN: 1556-0864; 1556-1380
von Pawel, J.; Eberhardt, Wilfried; Reck, M.; Eschbach, C.; Fischer, J. R.; Schuette, W.; Bohnet, S.; Heeger, S.; Schumacher, K. M.; von Heydebreck, A.; Pirker, R.

Tumor epidermal growth factor receptor (EGFR) expression as a predictive biomarker of survival in FLEX study patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy plus cetuximab as first-line therapy

In: Onkologie Jg. 34 (2011) Nr. Suppl. 6, S. 121

ISSN: 0378-584X; 1423-0240
Christoph, Daniel; Wittkowski, Lukas; Stattaus, Jörg; Pöttgen, Christoph; Keyvani, Kathy; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried

Very Late and Isolated Leptomeningeal Relapse of a Pulmonary Adenocarcinoma Presenting as Dementia

In: Onkologie Jg. 34 (2011) Nr. 6, S. 316 - 320

ISSN: 1423-0240

Online Volltext: dx.doi.org/
O'Byrne, K. J.; Von Pawel, J.; Vynnychenko, I.; Zatloukal, P.; De Marinis, F.; Eberhardt, Wilfried; Paz-Ares, L. G.; Schumacher, K.; Gatzemeier, U.; Pirker, R.

First-cycle rash as a clinical marker in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line chemotherapy (CT) plus cetuximab : Efficacy by histology

In: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. Suppl. 15, S. 7556

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Debus, Jürgen; Eberhardt, Wilfried; Hoffmann, Hans; Passlick, Bernward; Rübe, Christian; Thomas, Michael

Grenzlinien der Kuration

In: Oncology Research and Treatment Jg. 33 (2010) Nr. Suppl. 5, S. 12 - 20

ISSN: 1423-0240; 0378-584X; 2296-5262; 2296-5270

Online Volltext: dx.doi.org/ (Open Access)
Pöttgen, Christoph; Eberhardt, Wilfried; Gauler, Thomas; Krbek, Thomas; Berkovic, Katharina; Abu Jawad, Jehad; Korfee, Sönke; Teschler, Helmut; Stamatis, Georgios; Stuschke, Martin

Intensified high-dose chemoradiotherapy with induction chemotherapy in patients with locally advanced non-small-cell lung cancer-safety and toxicity results within a prospective trial

In: International Journal of Radiation Oncology Biology Physics Jg. 76 (2010) Nr. 3, S. 809 - 815

ISSN: 0360-3016; 1879-355X

Online Volltext: dx.doi.org/
Weder, Walter; Collaud, Stéphane; Eberhardt, Wilfried; Hillinger, Sven; Welter, Stefan; Stahel, Rolf; Stamatis, Georgios

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer

In: The Thoracic and Cardiovascular Surgeon Jg. 139 (2010) Nr. 6, S. 1424 - 1430

ISSN: 1439-1902; 0040-6384

Online Volltext: dx.doi.org/ (Open Access)
Schütt, Philipp; Schütt, Birgit; Switala, Magdalena; Bauer, Sebastian; Stamatis, Georgios; Opalka, Bertram; Eberhardt, Wilfried; Schuler, Martin; Horn, Peter; Rebmann, Vera

Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients

In: Human Immunology Jg. 71 (2010) Nr. 5, S. 489 - 495

ISSN: 0198-8859; 1879-1166

Online Volltext: dx.doi.org/
Goeckenjan, Gerd; Sitter, Helmut; Thomas, Michael Byrne; Branscheid, Detlev; Flentje, Michael P.; Griesinger, Frank; Niederle, Norbert; Stuschke, Martin; Blum, Torsten G.; Deppermann, Karl Matthias; Ficker, Joachim H.; Freitag, Lutz; Lübbe, Andreas Stephan; Reinhold, Thomas; Späth-Schwalbe, Ernst; Ukena, Dieter; Wickert, M.; Wolf, Martin; Andreas, Stefan; Auberger, Thomas; Baum, Richard P.; Baysal, B.; Beuth, Joseph; Bickeböller, Heike; Böcking, Alfred H.; Bohle, Rainer Maria; Brüske, Irene; Burghuber, Otto C.; Dickgreber, Nicolas J.; Diederich, Stefan; Dienemann, Hendrik C.; Eberhardt, Wilfried; Eggeling, Stephan; Fink, Thomas H.; Fischer, Berthold M.; Franke, M.; Friedel, Godehard; Gauler, Thomas; Gütz, Sylvia; Hautmann, Hubert; Hellmann, Andreas; Hellwig, Dirk; Herth, Felix J.F.; Heußel, Claus Peter; Hilbe, Wolfgang; Hoffmeyer, Frank; Horneber, Markus A.; Huber, Rudolf Maria; Hübner, Jutta; Kauczor, Hans Ulrich; Kirchbacher, Klaus; Kirsten, Detlef K.; Kraus, Thomas; Lang, Susanne M.; Martens, Uwe M.; Mohn-Staudner, Andrea; Müller, Klaus Michael; Müller-Nordhorn, Jacqueline; Nowak, Dennis A.; Ochmann, Uta; Passlick, Bernward; Petersen, Iver; Pirker, Robert A.; Pokrajac, Boris; Reck, Martin; Riha, Susanne; Rübe, Christian E.; Schmittel, Alexander; Schönfeld, Nicolas; Schütte, Wolfgang; Serke, Monika; Stamatis, Georgios; Steingräber, Maria; Steins, Martin B.; Stoelben, Erich; Swoboda, Lothar; Teschler, Helmut; Tessen, Hans Werner; Weber, Martin R.; Werner, Andreas; Wichmann, Heinz-Erich; Irlinger Wimmer, E.; Witt, Christian; Worth, Heinrich

Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms

In: Pneumologie Jg. 64 (2010) Nr. Suppl. 2, S. e1 - e164

ISSN: 0934-8387; 1438-8790

Online Volltext: dx.doi.org/
Hoffmann, Andreas-Claudius; Gauler, Thomas; Parr, A.; Eberhardt, Wilfried; Schuler, Martin

Use of ERCC1 expression levels in circulating tumor cells to predict to response to platinum-based chemotherapy in patients with non-small cell lung cancer

In: Journal of Clinical Oncology (JCO) Jg. 28 S (2010) Nr. 15, S. Abstract7512

ISSN: 0732-183X; 1527-7755
O'Byrne, K.; Eberhardt, Wilfried; Storkel, S.; Schumacher, K.; Heeger, S.; Stroh, C.; Celik, I.; von Heydebreck, A.; Pirker, R.

Use of a Continuous EGFR IHC Scoring Method Reveals Association between Tumor Response and ECFR Expression Levels for Patients Receiving Cetuximab plus CT versus CT Alone in the Phase III Trial FLEX in Advanced NSCLC

In: J Thorac Oncol Jg. 5 (2010) Nr. 12 Suppl. 7, S. S558 - S559

ISSN: 1556-0864; 1556-1380

Online Volltext: dx.doi.org/
Herbst, Roy S.; Sun, Yan; Eberhardt, Wilfried; Germonpré, Paul R.; Saijo, Nagahiro; Zhou, Caicun; Wang, Jiejun; Li, Longyun; Kabbinavar, Fairooz F.; Ichinose, Yukito; Qin, Shukui; Zhang, Li; Biesma, Bonne; Heymach, John V.; Langmuir, Peter B.; Kennedy, Sarah J.; Tada, Hirohito; Johnson, Bruce E.

Vandetanib plus docetaxel versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer (ZODIAC) : a double-blind, randomised, phase 3 trial

In: The Lancet Oncology Jg. 11 (2010) Nr. 7, S. 619 - 626

ISSN: 1470-2045; 1474-5488

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Theegarten, Dirk; Eberhardt, Wilfried; Levegrün, Sabine; Gauler, Thomas; Krbek, Thomas; Stamatis, Georgios; Teschler, Helmut; Kuehl, Hilmar; Bockisch, Andreas; Stuschke, Martin

Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancer

In: Oncology Jg. 73 (2008) Nr. 5-6, S. 316 - 323

ISSN: 0030-2414; 1423-0232

Online Volltext: dx.doi.org/
Marra, Alex; Eberhardt, Wilfried; Pöttgen, Christoph; Theegarten, Dirk; Korfee, Sönke; Gauler, Thomas; Stuschke, Martin; Stamatis, Georgios

Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour

In: European Respiratory Journal Jg. 29 (2007) Nr. 1, S. 117 - 127

ISSN: 0903-1936; 1399-3003

Online Volltext: dx.doi.org/ (Open Access)
Pöttgen, Christoph; Levegrün, Sabine; Theegarten, Dirk; Marnitz, Simone; Grehl, Sara; Pink, Roman; Eberhardt, Wilfried; Stamatis, Georgios; Gauler, Thomas; Antoch, Gerald; Bockisch, Andreas; Stuschke, Martin

Value of ¹⁸F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy

In: Clinical Cancer Research Jg. 12 (2006) Nr. 1, S. 97 - 106

ISSN: 1078-0432; 1557-3265

Online Volltext: dx.doi.org/

Vorworte / Nachworte

Sebastian, Martin; Stratmann, Jan Alexander; Eberhardt, Wilfried

Too Good to be True?

In: Journal of Thoracic Oncology Jg. 16 (2021) Nr. 4, S. 507 - 508

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Eberhardt, Wilfried

How should we choose the best therapy for elderly patients with stage III non-small-cell lung cancer?

In: Journal of Clinical Oncology (JCO) Jg. 35 (2017) Nr. 25, S. 2860 - 2862

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Eberhardt, Wilfried; Hepp, R.

Staging of the Mediastinum : Are We Already There?

In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. 9, S. 1114 - 1115

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/
Eberhardt, Wilfried

Compassionate use programs or phase IV trials of innovative molecular targeted drugs in lung cancer: Deal or no deal?

In: Journal of Thoracic Oncology Jg. 5 (2010) Nr. 10, S. 1495 - 1497

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)

Abstracts

Lanzafame, H.; Hirmas, N.; Schuler, Martin; Darwiche, Kaid; Eberhardt, Wilfried E. E.; Aigner, Clemens; Stuschke, Martin; Kessler, Lukas; Pabst, K. M.; Barbato, F.; Rischpler, Christoph; Hautzel, H.; Herrmann, Ken; Fendler, Wolfgang;

68GA-FAPI PET/CT in the evaluation of Non-Small Cell Lung Cancer (NSCLC)
EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,

In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. Supplement 1, S. S107

ISSN: 1619-7089; 1619-7070; 0340-6997; 1432-105X

Online Volltext: dx.doi.org/ (Open Access)
Griesinger, F.; Sebastian, M.; Bethge, A.; Christopoulos, P.; Hoffknecht, P.; Waller, C.; Benkelmann, R.; Jänicke, M.; Fleitz, A.; Hanselmann, J.; Hipper, A.; Groth, A.; Weichert, W.; Nusch, A.; Rauh, J.; Fietz, T.; Illmer, T.; Depenbusch, R.; Eberhardt, Wilfried; Thomas, M.

EGFR exon 20 insertion mutations in patients with locally advanced or metastatic NSCLC in the German prospective, CRISP Registry real-world cohort (AIO-TRK-0315)

In: Annals of Oncology Jg. 33 (2022) Nr. Suppl. 2, S. 54 - S55

ISSN: 1569-8041; 0923-7534

Online Volltext: dx.doi.org/
Jehn, B. L.; Waelscher, J.; Wessendorf, Thomas; Livingstone, Elisabeth; Zimmer, Lisa; Metzenmacher, M.; Eberhardt, Wilfried; Theegarten, Dirk; Taube, Christian; Bonella, Francesco;

Immune Checkpoint Inhibitor (ICI)-associated Pulmonary Manifestations (ICI-LM): Characterization of HRCT and BAL Findings
62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.; 25.–28.05.2022; Leipzig,

In: Pneumologie Jg. 76 (2022) Nr. Supplement 1, S. S52

ISSN: 0934-8387; 1438-8790

Online Volltext: dx.doi.org/
Eberhardt, Wilfried; Passlick, B.; Stuschke, Martin; Gröschel, A.; Christopoulos, P.; Reck, M.; Ludwig, P.; Hipper, A.; Chiabudini, M.; Spring, L.; Jänicke, M.; Andres-Pons, A.; Christoph, D. C.; Bernhardt, C.; Reiser, M.; Sebastian, M.; Griesinger, F.; Thomas, M.;

Klinische Plattform zur Erforschung molekularer Testung, Behandlung und Krankheitsverlauf von Patienten mit Lungenkrebs (CRISP) : Real-World Evidence zu NSCLC Patienten behandelt mit Radiochemotherapie in Deutschland - AIO-TRK-0315
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,

In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 269 - 270

ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584X

Online Volltext: dx.doi.org/ (Open Access)
Eberhardt, Wilfried; Pöttgen, Christoph; Gauler, Thomas; Schulte, C; Friedel, G.; Kopp, H.-G.; Fischer, B.; Schmidberger, H.; Kimmich, M.; Budach, W.; Cordes, S.; Metzenmacher, M.; de Los Rios, R. Hepp; Spengler, W.; De Ruysscher, D.; Belka, C.; Welter, S.; Brintrup, D. Luetke; Guberina, M.; Oezkan, F.; Darwiche, Kaid; Schuler, Martin; Jöckel, Karl-Heinz; Aigner, Clemens; Stamatis, Georgios; Stuschke, Martin

Long-term Survival and Competing Risks of Death in the ESPATUE Randomized Phase-III Trial in Stage III NSCLC

In: Journal of Thoracic Oncology Jg. 17 (2022) Nr. 9, S. 65

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/
Sebastian, M.; Griesinger, F.; von der Heyde, E.; Dörfel, S.; Wiegand, J.; Schiefer, C.; Losem, C.; Jänicke, M.; Fleitz, A.; Zacharias, S.; Hipper, A.; Dietel, C.; Bleckmann, A.; Benkelmann, R.; Boesche, M.; Grah, C.; Müller, A.; Eberhardt, Wilfried E. E.; Thomas, M.; ; CRISP Registry Group

Patient-reported outcomes vor und während der COVID-19-Pandemie bei Patienten mit lokal fortgeschrittenem oder metastasiertem nicht-kleinzelligen Lungenkarzinom in Deutschland : Daten aus der prospektiven CRISP Registerplattform (AIO-TRK-0315)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,

In: Oncology Research and Treatment Jg. 45 (2022) Nr. Supplement 2, S. 127

ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584X

Online Volltext: dx.doi.org/ (Open Access)
Guberina, M.; Pöttgen, Christoph; Guberina, N.; Gauler, Thomas; Metzenmacher, M.; Wiesweg, Marcel; Richlitzki, C.; Plönes, T.; Forsting, Michael; Wetter, Axel; Herrmann, Ken; Hautzel, H.; Darwiche, Kaid; Theegarten, Dirk; Aigner, Clemens; Schuler, Martin; Eberhardt, Wilfried E. E.; Stuschke, Martin;

Robuste und lang-andauernde Wirksamkeit der Durvalumab-Konsolidierung bei NSCLC im Stadium III nach Induktionschemotherapie und definitiver Radiochemotherapie : Fokus auf Behandlungsauswahl und prognostische Faktoren
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,

In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 198 (2022) Nr. Supplement 1, S. S15

ISSN: 1439-099X; 0179-7158

Online Volltext: dx.doi.org/ (Open Access)
Jehn, Lutz-Bernhard; Wälscher, Julia; Wessendorf, Thomas; Livingstone, Elisabeth; Zimmer, Lisa; Metzenmacher, Martin; Eberhardt, Wilfried; Theegarten, Dirk; Bonella, Francesco

Bronchoalveolar lavage fluid (BALF) findings in patients with immune checkpoint inhibitor (ICI)-associated interstitial pneumonia (IP)

In: European Respiratory Journal (ERJ) (2021)

ISSN: 0903-1936; 1399-3003

Online Volltext: dx.doi.org/
Griesinger, F.; Sebastian, M.; Brückl, W.; Hummel, H.-D.; Jaeschke, B.; Kern, J.; Schumann, C.; Wesseler, C.; Jänicke, M.; Fleitz, A.; Zacharias, S.; Hipper, A.; Groth, A.; Weichert, W.; Dörfel, S.; Petersen, V.; Schröder, J.; Wilke, J.; Eberhardt, Wilfried E. E.; Thomas, M.; ; CRISP Registry Group

Checkpoint inhibitor monotherapy in potentially study-eligible or non-study-eligible NSCLC patients in the German CRISP Registry real-world cohort (AIO-TRK-0315)
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,

In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 111

ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584X

Online Volltext: dx.doi.org/ (Open Access)
Griesinger, Frank; Sebastian, Martin; Brückl, Wolfgang M.; Hummel, Horst Dieter; Jaeschke, B.; Kern, J.; Schumann, Christian; Wesseler, Claas; Jänicke, M.; Fleitz, A.; Zacharias, Stefan; Hipper, Annette; Groth, Anne; Weichert, Wilko; Dörfel, Steffen; Petersen, Volker; Schröder, Jan Klaus; Wilke, Jochen; Eberhardt, Wilfried; Thomas, Michael

Checkpoint inhibitor monotherapy in potentially study-eligible or non-study-eligible NSCLC patients in the German CRISP registry real-world cohort (AIO-TRK-0315)

In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. S1015 - S1016

ISSN: 1569-8041; 0923-7534

Online Volltext: dx.doi.org/ (Open Access)
Stuschke, Martin; Passlick, B.; Groeschel, A.; Christopoulos, P.; Reck, M.; Grah, C.; Groth, A.; Hipper, A.; Chiabudini, M.; Fleitz, A.; Jaenicke, M.; Spring, L.; Christoph, Daniel; Bernhardt, C.; Thomas, M.; Eberhardt, Wilfried

Clinical Platform for Research into molecular Testing, Treatment and Disease Progression in Patients with Lung Cancer (CRISP) : First Real-World Evidence on Stage II and III NSCLC in Germany - AIO-TRK-0315

In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. S11 - S12

ISSN: 1439-099X; 0179-7158
Eberhardt, Wilfried E. E.; Passlick, B.; Stuschke, Martin; Gröschel, A.; Christopoulos, P.; Reck, M.; Grah, C.; Groth, A.; Hipper, A.; Chiabudini, M.; Fleitz, A.; Jänicke, M.; Spring, L.; Christoph, D. C.; Bernhardt, C.; Reiser, M.; Zahn, M.-O.; Sebastian, M.; Griesinger, F.; Thomas, M.; CRISP Registry Group;

Clinical research platform Into molecular testing, treatment and outcome of non-Small cell lung carcinoma patients (CRISP) : First real-world evidence of NSCLC Stage II and III in Germany - AIO-TRK-0315
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,

In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 3

ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584X

Online Volltext: dx.doi.org/ (Open Access)
Gröschel, A.; Passlick, B.; Stuschke, Martin; Christopoulos, P.; Reck, M.; Grah, C.; Groth, A.; Hipper, A.; Chiabudini, M.; Fleitz, A.; Jänicke, M.; Spring, L.; Christoph, Daniel; Bernhardt, C.; Reiser, M.; Zahn, M-O.; Sebastian, M.; Griesinger, F.; Thomas, M.; Eberhardt, Wilfried

Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patients (CRISP) : First real-world evidence of NSCLC stage II and III in Germany - AIO-TRK-0315

In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. S935 - S936

ISSN: 1569-8041; 0923-7534

Online Volltext: dx.doi.org/ (Open Access)
Christoph, Daniel; Ferdinandus, Justin; Metzenmacher, Martin; Kessler, Peter; Umutlu, Lale; Aigner, Clemens; Kambartel, Karl-Otto; Grünwald, Viktor; Eberhardt, Wilfried; Fendler, Wolfgang; Herrmann, Ken; Faehling, Martin

Complete metabolic response in advanced non-small cell lung cancer patients with prolonged response to immune checkpoint inhibitor therapy

In: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 9050 - 9050

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Guberina, M.; Herrmann, Ken; Pöttgen, Christoph; Guberina, N.; Hoffmann, C.; Ploenes, T.; Gauler, Thomas; Wetter, Axel; Umutlu, Lale; Hautzel, H.; Theegarten, Dirk; Schuler, Martin; Eberhardt, Wilfried; Metzenmacher, M.; Wiesweg, Marcel; Aigner, Clemens; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Stuschke, Martin

EBUS-TBNA and [F-18] FDG-PET/CT for precise Target Volume Definition prior to Chemoradiotherapy : Lymphonodular Spreading Patterns in Stage III NSCLC

In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 142

ISSN: 1439-099X; 0179-7158
Fischedick, G.; Pöttgen, Christoph; Lübcke, Wolfgang; Gauler, Thomas; Guberina, M.; Guberina, N.; Pierscianek, D.; Livingstone, Elisabeth; Hense, Jörg; Eberhardt, Wilfried; Stuschke, Martin

Image-guided ablative Radiotherapy for Patients with multiple cerebral Metastases using Precision helical Irradiation

In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 183

ISSN: 1439-099X; 0179-7158
Pöttgen, Christoph; Gauler, Thomas; Guberina, M.; Pierscianek, D.; Wrede, Karsten; Wiesweg, Marcel; Eberhardt, Wilfried; Schuler, Martin; Stuschke, Martin

Re-Irradiation of cerebral Metastases after prophylactic Brain Skull irradiation in small-cell neuroendocrine Lung Cancer (SCLC)

In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 176

ISSN: 1439-099X; 0179-7158
Chan, M.; Guberina, Marko; Stuschke, Martin; Pöttgen, Christoph; Aigner, Clemens; Eberhardt, Wilfried; Hautzel, Hubertus; Guberina, Nika

Evaluation der Korrelation des anatomischen und funktionellen CT-Ventilations- und SPECT-Perfusions- Lungenvolumens bei Patienten mit Nicht-kleinzelligem Lungenkarzinom

In: Strahlentherapie und Onkologie Jg. 196 (2020) Nr. S1, S. S145 - S146

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/ (Open Access)
Griesinger, Frank; Sebastian, M.; Fleitz, Annette; Hipper, Annette; Buller, M.; Jaenicke, Martina; Eberhardt, Wilfried; Thomas, Michael;

How does the SarsCov2 epidemic the treatment of patients with lung cancer in Germany? : Data from the prospective CRISP registry
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,

In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 137

ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584X

Online Volltext: dx.doi.org/ (Open Access)
Guberina, Marko; Pöttgen, Christoph; Guberina, Nika; Hautzel, Hubertus; Herrmann, Ken; Theegarten, Dirk; Aigner, Clemens; Plones, Till; Gauler, Thomas; Eberhardt, Wilfried; Schuler, Martin; Karpf-Wissel, Rüdiger; Darwiche, Kaid; Stuschke, Martin

Lymphknoten-Staging von lokal fortgeschrittenen, nicht kleinzelligen Lungenkarzinomen (NSCLC) : Wert von [18F] FDG-PET/CT und EBUS/TBNA zur Festlegung des Zielvolumens bei definitiver Radiotherapie in kurativer Intention

In: Strahlentherapie und Onkologie Jg. 196 (2020) Nr. S1, S. S143

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/ (Open Access)
Pöttgen, Christoph; Plajer, D.; Gauler, Thomas; Guberina, Marko; Santiago, Alina; Guberina, Nika; Eberhardt, Wilfried; Schuler, Martin; Darwiche, Kaid; Plönes, Till; Aigner, Clemens; Stuschke, Martin

Optimierung prognostischer Modelle für das Überleben von Patienten mit lokal fortgeschrittenen kleinzelligen Lungenkarzinomen nach definitiver Radiochemotherapie mittels künstlicher Intelligenz

In: Strahlentherapie und Onkologie Jg. 196 (2020) Nr. S1, S. S57 - S58

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/ (Open Access)
Kraskowski, O.; Eberhardt, Wilfried; Metzenmacher, Martin; Zaun, Gregor; McCutcheon, A.; Schmid, Kurt Werner; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Kasper, Stefan; Hense, Jörg; Gruenwald, Viktor; Wiesweg, Marcel; Schuler, Martin; Pogorzelski, Michael;

Patients with metastatic EGFR-mutated non-small cell lung cancer (NSCLC) show highly favorable outcomes with treatment sequences provided at a comprehensive cancer center
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,

In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 137

ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584X

Online Volltext: dx.doi.org/ (Open Access)
Sebastian, M.; Eberhardt, Wilfried; Losem, C.; Bernhardt, C.; Maintz, C.; Marschner, N.; Jaenicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Hoffknecht, P.; Grah, C.; Rittmeyer, A.; Griesinger, F.; Thomas, M.;

Patients with metastatic non-small cell lung cancer and PD-L1 expression in Germany : Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28. März 2020 (verschoben auf 2021), Leipzig,

In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S127

ISSN: 0934-8387; 1438-8790

Online Volltext: dx.doi.org/
Griesinger, F.; Eberhardt, Wilfried; Nusch, A.; Reiser, M.; Zahn, M.O.; Marschner, N.; Jaenicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Waller, C.; Reck, M.; Christopoulos, P.; Sebastian, M.; Thomas, M.;

Patients with metastatic non-small cell lung cancer and targetable molecular alterations in Germany : Treatment and first outcome data from the prospective German Registry Platform CRISP (AIO-TRK-0315)
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28. März 2020 (verschoben auf 2021), Leipzig,

In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S132

ISSN: 0934-8387; 1438-8790

Online Volltext: dx.doi.org/
Griesinger, F.; Eberhardt, Wilfried; Bruch, H.R.; Rauh, J.; von der Heyde, E.; Marschner, N.; Jaenicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Sadjadian, P.; Metzenmacher, M.; Gleiber, W.; Sebastian, M.; Thomas, M.;

Patients with metastatic non-small cell lung cancer without molecular alterations or PD-L1 expression in Germany : Treatment and first outcome from the prospective German Registry Platform CRISP (AIO-TRK-0315)
61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V.; 25.–28. März 2020 (verschoben auf 2021), Leipzig,

In: Pneumologie Jg. 74 (2020) Nr. Suppl. 1, S. S15 - S16

ISSN: 0934-8387; 1438-8790

Online Volltext: dx.doi.org/
Griesinger, F.; Eberhardt, Wilfried; Hoffknecht, P.; Metzenmacher, Martin; Wehler, T.; Kokowski, K.; Alt, J.; Schütte, W.; Jänicke, M.; Fleitz, A.; Zacharias, S.; Hipper, A.; Buller, M.; Weichert, W.; Groschek, M.; Heyde, E. von der; Rauh, J.; Dechow, T.; Sebastian, M.; Thomas, M.;

Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations with a special focus on KRAS G12C
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,

In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 135

ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584X

Online Volltext: dx.doi.org/ (Open Access)
Griesinger, F.; Eberhardt, Wilfried; Hoffknecht, Petra; Metzenmacher, Martin; Wehler, T.; Kokowski, K.; Alt, Jürgen; Schütte, Wolfgang; Jänicke, Martina; Fleitz, Annette; Zacharias, Steffen; Hipper, A.; Buller, M.; Weichert, Wilko; Groschek, M.; Heyde, E. von der; Rauh, J.; Dechow, T.; Sebastian, M.; Thomas, M.;

Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations with a special focus on KRAS G12C
ESMO Virtual Congress 2020, 19 – 21 September / 16 – 18 October 2020,

In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S872

ISSN: 0923-7534; 1569-8041

Online Volltext: dx.doi.org/ (Open Access)
Guberina, Nika; Pöttgen, Christoph; Sahin, Zumrut; Aigner, Clemens; Eberhardt, Wilfried; Guberina, Marko; Indenkämpen, Frank; Stuschke, Martin

Welche Standard-PTV-Säume werden bei gegateter Strahlentherapie in Exspiration bei lokal fortgeschrittenen Lungenkarzinomen nach online-Navigation benötigt?

In: Strahlentherapie und Onkologie Jg. 196 (2020) Nr. S1, S. S58

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/ (Open Access)
Borchert, S.; Wessolly, M.; Schmeller, J.; Mairinger, E.; Kollmeier, J.; Hager, T.; Mairinger, T.; Herold, T.; Christoph, Daniel; Walter, R.; Eberhardt, Wilfried; Plönes, T.; Wohlschläger, Jeremias; Aigner, Clemens; Schmid, K.; Mairinger, F.

Defects in Homologous Recombination Repair Indicates Susceptibility for Olaparib Treatment in Malignant Pleural Mesothelioma

In: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, Supplement, S. S482

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Schmeller, Jan; Mairinger, Fabian; Wessolly, Michael; Mairinger, Elena; Borchert, Sabrina; Kollmeier, Jens; Hager, Thomas; Mairinger, Thomas; Christoph, Daniel; Walter, Robert; Eberhardt, Wilfried; Plönes, Till; Wohlschläger, Jeremias; Jasani, Bharat; Schmid, Kurt Werner; Bankfalvi, Agnes;

Immunohistochemically Detectable Metallothionein Expression in Malignant Pleural Mesotheliomas is Strongly Associated with Early Failure to Platin-Based Chemotherapy
Herbsttagung der Sektion Zellbiologie in der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Essen, 09.–10.11.2018,

In: Pneumologie Jg. 73 (2019) Nr. 02, S. 110 - 111

ISSN: 0934-8387; 1438-8790

Online Volltext: dx.doi.org/
Hegedüs, Balasz; Wohlschläger, Jeremias; Wessolly, Michael; Hager, Thomas; Mairinger, Elena; Suckrau, Pia; Eberhardt, Wilfried; Mairinger, Fabian; Schmeller, Jan; Herold, Thomas; Schmid, Kurt Werner; Aigner, Clemens; Borchert, Sabrina; Bankfalvi, Agnes; Walter, Robert;

Influence of Methallothionein Expression on Sensitivity Against Platin Compounds in Human Malignant Pleural Mesothelioma Cell Lines – Knock-Down of Gene Expression as New Therapeutic Approach?
Herbsttagung der Sektion Zellbiologie in der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Essen, 09.–10.11.2018,

In: Pneumologie Jg. 73 (2019) Nr. 02, S. 115

ISSN: 0934-8387; 1438-8790

Online Volltext: dx.doi.org/
Sebastian, M.; Eberhardt, Wilfried; Losem, C.; Bernhardt, C.; Maintz, C.; Marschner, N.; Jänicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Hoffknecht, P.; Grah, C.; Rittmeyer, A.; Griesinger, F.; Thomas, M.;

Patients with metastatic non-small cell lung cancer and PD-L1 expression in Germany : treatment and first outcome from the prospective German registry platform CRISP (AIO-TRK-0315)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,

In: Oncology Research and Treatment Jg. 42 (2019) Nr. Suppl 4, S. 113

ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262

Online Volltext: dx.doi.org/ (Open Access)
Griesinger, F.; Eberhardt, Wilfried; Bruch, H.-R.; Rauh, J.; Heyde, E. von der; Marschner, N.; Jänicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Sadjadian, P.; Metzenmacher, M.; Gleiber, W.; Sebastian, M.; Thomas, M.;

Patients with metastatic non-small cell lung cancer without molecular alterations or PD-L1 expression in Germany : Treatment and first outcome from the prospective German registry platform CRISP (AIO-TRK-0315)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,

In: Oncology Research and Treatment Jg. 42 (2019) Nr. Suppl 4, S. 109

ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262

Online Volltext: dx.doi.org/ (Open Access)
Griesinger, F.; Eberhardt, Wilfried; Nusch, A.; Reiser, M.; Zahn, M.-O.; Marschner, N.; Jänicke, M.; Fleitz, A.; Spring, L.; Sahlmann, J.; Karatas, A.; Hipper, A.; Weichert, W.; Waller, C. F.; Reck, M.; Christopoulos, P.; Sebastian, M.; Thomas, M.;

Patients with metastatic non-small cell lung carcinoma and targetable oncogenic molecular alterations in Germany : Treatment and first outcome data from the prospective German registry CRISP (AIO-TRK-0315)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin,

In: Oncology Research and Treatment Jg. 42 (2019) Nr. Suppl 4, S. 107

ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262

Online Volltext: dx.doi.org/ (Open Access)
Plones, T.; Schmeller, J.; Christoph, Daniel; Walter, R.; Hager, T.; Schmid, Kurt Werner; Borchert, S.; Bankfalvi, Agnes; Mairinger, T.; Mairinger, E.; Mairinger, F.; Wohlschlager, J.; Eberhardt, Wilfried; Wessolly, M.; Kollmeier;

Processing Escapes : an Alternative Explanation for Immune Therapy Resistance
Herbsttagung der Sektion Zellbiologie in der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Essen, 09.–10.11.2018,

In: Pneumologie Jg. 73 (2019) Nr. 02, S. 111 - 112

ISSN: 0934-8387; 1438-8790

Online Volltext: dx.doi.org/
Wessolly, M.; Streubel, A.; Werner, R.; Borchert, S.; Stephan-Falkenau, S.; Griff, S.; Mairinger, E.; Schmeller, J.; Walter, R.; Bauer, T.; Eberhardt, Wilfried; Blum, T.; Schmid, Kurt Werner; Kollmeier, J.; Mairinger, F.; Mairinger, T.

Processing Escapes : Novel Resistance Mechanisms Under Immune Checkpoint Inhibition in NSCLC

In: Journal of Thoracic Oncology Jg. 14 (2019) Nr. 10, Supplement, S. S450

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Exner, J.-P.; Nadjm, S.; Gauler, Thomas; Pöttgen, Christoph; Krebs, B.; Cheufou, D.; Darwiche, Kaid; Metzenmacher, M.; Theegarten, Dirk; Umutlu, Lale; Hoffmann, Andreas-Claudius; Oezkan, F.; Aigner, Clemens; Taube, Christian; Schuler, Martin; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried;

Long-term Survival (LT-S) and Survivorship Program (SS-P) of Lung Cancer (LC) Patients (Pts) - B : Implications for Follow-up (F-up) and Surveillance (SV)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,

In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 109 - 110

ISSN: 2296-5270; 2296-5262

Online Volltext: dx.doi.org/ (Open Access)
Nadjm, S.; Exner, J. P.; Gauler, Thomas; Pöttgen, Christoph; Darwiche, Kaid; Cheufou, D.; Krebs, B.; Metzenmacher, M.; Oezkan, F.; Rebmann, Vera; Umutlu, Lale; Deuschl, C.; Li, Y.; Lahner, Harald; Christoph, Daniel; Hoiczyk, M.; Witzke, Oliver; Hoffmann, Andreas-Claudius; Aigner, Clemens; Theegarten, Dirk; Taube, Christian; Schuler, Martin; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried;

Long-term Survival(LTS) and Survivorship Program(SS-P) of Lung Cancer(LC) Patients(Pts). Investigations(Invest) on LT-toxicities(Tox) and late morbidities(Morb)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,

In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 108

ISSN: 2296-5270; 2296-5262

Online Volltext: dx.doi.org/ (Open Access)
Griesinger, F.; Eberhardt, Wilfried; Nusch, A.; Reiser, M.; Losem, C.; Ketzler-Henkel, S.; Zahn, M.-O.; Marschner, N.; Jänicke, M.; Fleitz, A.; Spring, L.; Karatas, A.; Hipper, A.; de Wit, M.; Metzenmacher, M.; Waller, C.; Kern, J.; Weichert, W.; Sebastian, M.; Thomas, M.;

Molecular testing, frequency of molecular alterations and first-line treatment of patients with non-small cell lung carcinoma (NSCLC) in Germany : First results from the prospective German Registry CRISP (AIO-TRK-0315)
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,

In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 1, S. 17 - 17

ISSN: 2296-5270; 2296-5262

Online Volltext: dx.doi.org/ (Open Access)
Griesinger, Frank; Eberhardt, Wilfried; Nusch, Arnd; Reiser, Marcel; Zahn, Mark-Oliver; Marschner, Norbert Walter; Jänicke, Martina; Fleitz, Annette; Spring, Lisa; Sahlmann, Joerg; Karatas, Aysun; Hipper, Annette; Weichert, Wilko; Rittmeyer, Achim; Metzenmacher, Martin; Waller, Cornelius F.; Sebastian, Martin; Thomas, Michael

Molecular testing, frequency of molecular alterations and targeted 1st-line treatment of patients with non-small cell lung carcinoma in Germany : First results from the prospective German Registry CRISP (AIO-TRK-0315)

In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. e21236 - e21236

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Thomas, M.; Grohe, C.; Eberhardt, Wilfried; Rawluk, J.; Reck, M.; Laack, E.; Wesseler, C.; Rittmeyer, Achim; Alt, J.; Reinmuth, N.; Griesinger, F.; Kern, J.;

POSEIDON : A phase 3 study of first-line Durvalumab +/- Tremelimumab plus chemotherapy vs chemotherapy alone in metastatic NSCLC
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; Wien, 28. September - 2. Oktober 2018,

In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 295

ISSN: 2296-5262; 2296-5270

Online Volltext: dx.doi.org/ (Open Access)
Griesinger, Frank; Eberhardt, Wilfried; Nusch, Arnd; Reiser, M.; Bernhardt, C.; Marschner, Norbert; Jaenicke, M.; Fleitz, Annette; Spring, Lisa; Sahlmann, Jörg; Karatas, A.; Hipper, A.; Weichert, Wilko; Rittmeyer, Achim; Bischoff, Helge G.; Waller, Cornelius F.; Thomas, Michael

Testing for and frequency of molecular alterations in patients with advanced NSCLC in Germany : Results from the prospective German registry CRISP (AIO-TRK-0315)

In: Annals of Oncology Jg. 29 (2018) Nr. Suppl. 8, S. viii515

ISSN: 0923-7534; 1569-8041

Online Volltext: dx.doi.org/ (Open Access)
Pöttgen, Christoph; Abu Jawad, Jehad; Indenkampen, F.; Heintz, Martin; Ebenau, M.; Wienczierz, M.; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin

Vergleich der 3D-Navigation der atemabhängigen Tumor-Position mittels stereoskopischer Röntgenaufnahmen (ExacTrac) bzw. kV-ConeBeam-CTs bei der kurativen Radiotherapie von Lungenkarzinomen

In: Strahlentherapie und Onkologie Jg. 193 (2017) Nr. Suppl. 1, S. S79 - S80

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Schütte, W.; Thomas, M.; Eberhardt, Wilfried; Zirrgiebel, U.; Radke, S.; Dietel, M.;

Clinical Outcome of Targeted Therapy with Gefitinib in Metastatic NSCLC Depending on the Type of EGFR Mutation : A REASON Subgroup Analysis by Exon
Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,

In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 120

ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584X

Online Volltext: dx.doi.org/
Schütte, W.; Eberhardt, Wilfried; Schirmacher, P.; Dietel, M.; Zirrgiebel, U.; Radke, S.; Thomas, M.;

REASON : Factors influencing outcome in patients (pts) with NSCLC stage IIIB/IV and mutated EGF receptor (EGFR-M plus ) treated with gefitinib
Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,

In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 120

ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584X

Online Volltext: dx.doi.org/
Guberina, M.; Stuschke, Martin; Abu Jawad, Jehad; Gauler, Thomas; Gkika, E.; Bockisch, Andreas; Stamatis, Georgios; Eberhardt, Wilfried; Pöttgen, Christoph;

18 F-FDG-Response als prognostischer Faktor für das progressionsfreie Überleben bei der Behandlung von lokal fortgeschrittenen, nichtkleinzelligen Lungenkarzinonem : Trimodale Therapie vs. definitive Radiochemotherapie – Monozentrische Ergebnisse
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,

In: Strahlentherapie und Onkologie Jg. 191 (2015) Nr. Suppl.1, S. S21 - S22

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Levegrun, S.; Abu Jawad, Jehad; Lübcke, Wolfgang; Wittig, Andrea; Grehl, Sara; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin;

Ganzhirnbestrahlung (WBRT) versus Ganzhirnbestrahlung mit bildgeführter stereotaktischer Bestrahlung multipler cerebraler Metastasen mittels helikaler Tomotherapie – Toxizitätsanalyse einer randomisierten Studie
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,

In: Strahlentherapie und Onkologie Jg. 191 (2015) Nr. Suppl.1, S. 149

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Stuschke, Martin; Gauler, Thomas; Welter, Stefan; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried;

Hirnmetastasen bei Patienten mit lokal fortgeschrittenem NSCLC nach multimodaler kurativer Therapie in einem randomisierten Protokoll : prognostische Faktoren
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,

In: Strahlentherapie und Onkologie Jg. 191 (2015) Nr. Suppl. 1, S. 36 - 37

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Joerger, M.; Salamone, S. J.; von Pawel, J.; Kraff, S.; Fischer, J. R.; Eberhardt, Wilfried; Gauler, Thomas; Muller, L.; Reinmuth, N.; Reck, M.; Kimmich, M.; Mayer, F.; Kopp, H. G.; Behringer, D. M.; Ko, Y. D.; Fruh, M.; Hilger, Ralf A.; Roessler, M.; Moritz, B.; Miller, Michael; Jaehde, U.;

Randomized study of individualized, pharmacokinetically-guided dosing of paclitaxel combined with carboplatin in advanced non-small cell lung cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 9.-13. Oktober 2015, Basel, Schweiz,

In: Oncology Research and Treatment Jg. 38 (2015) Nr. Suppl. 5, S. 14 - 14

ISSN: 2296-5270; 0378-584X; 1423-0240; 2296-5262

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin;

Rekursive Partitions-Analyse prognostischer Faktoren für das Langzeit-Überleben nach trimodaler Therapie von Patienten mit lokal fortgeschrittenem NSCLC
21. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 25. Juni 2015, Hamburg,

In: Strahlentherapie und Onkologie Jg. 191 (2015) Nr. Suppl. 1, S. 23

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Schumann, C.; Engel-Riedel, W.; Kollmeier, J.; Grohe, C.; von Pawel, J.; Eberhardt, Wilfried; Gutz, S.; Nimmrich, I.; Weiss, C.; Potzner, M.; Serke, M.; Thomas, M.;

A multi-center phase II study investigating the combination of RAD001 (everolimus) with paclitaxel and carboplatin in first line treatment of patients with advanced Large Cell Lung Cancer with Neuroendocrine Differentiation (LCNEC) - a case report
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,

In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 88

ISSN: 2296-5262

Online Volltext: dx.doi.org/
Niemeyer, D.; Engel-Riedel, W.; Brockmann, M.; Grohe, C.; Schumann, C.; Kollmeier, J.; von Pawel, J.; Eberhardt, Wilfried; Gutz, S.; Weiss, C.; Potzner, M.; Nimmrich, I.; Serke, M.; Thomas, M.;

Case report from a patient with a histology shift from large cell neuroendocrine carcinoma of the lung (LCNEC) to small cell lung cancer (SCLC) after first line treatment in a trial investigating everolimus combined with paclitaxel and carboplatin
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,

In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 68 - 69

ISSN: 2296-5262

Online Volltext: dx.doi.org/
Köhler, Johannes; Schuler, Martin; Gauler, Thomas; Nopel-Dunnebacke, S.; Hoffmann, Andreas-Claudius; Kasper, Stefan; Nensa, Felix; Gomez, Benedikt; Hahnemann, M.; Breitenbücher, Frank; Cheufou, D.; Ozkan, F.; Darwiche, Kaid; Hoiczyk, M.; Welter, Stefan; Eberhardt, Wilfried; Teschler, Helmut; Stamatis, Georgios; Hahn, S. A.; Baraniskin, A.;

Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,

In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 5, S. 226 - 227

ISSN: 2296-5262

Online Volltext: dx.doi.org/
Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Veit, S.; Heinrich, V.; Gkika, E.; Hepp, R.; Welter, Stefan; Spengler, W.; Schmidberger, H.; Lutke-Brintrup, D.; Lehmann, Nils; Jöckel, Karl-Heinz; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried;

Definitive accelerated-hyperfractionated (AHF) Chemoradiotherapy (CRT) vs. neoadjuvant AHF-CRT and Surgery (S) for Patients with operable NSCLC in Stage IIIA(N2)/IIIB after Induction Chemotherapy (IND-C) : Results of a randomized Multicentre Study
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,

In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl. 1, S. 5 - 6

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Schuette, W.; Eberhardt, Wilfried; von der Schulenburg, JMG; Dietel, M.; Schirmacher, P.; Zaun, S.; Zirrgiebel, U.; Thomas, M.

Final Results from REASON, a Registry for the Epidemiologic and Scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV in Germany

In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 89

ISSN: 2296-5262

Online Volltext: dx.doi.org/
Stuschke, Martin; Abu Jawad, Jehad; Eberhardt, Wilfried; Grehl, Sara; Pöttgen, Christoph; Arnold, G.; Pfortner, R.; Gauler, Thomas; Schmeling, C.; Mohr, Christopher;

Neoadjuvant Docetaxel/Cisplatin/5-FU based radiochemotherapy (RT-CT) increases pathologic complete remissions and survival of patients with locally advanced oral cavity carcinomas in comparison to RT-CT with cisplatin alone followed by resection – a long term observational study
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,

In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl.1, S. 79

ISSN: 2296-5262

Online Volltext: dx.doi.org/
Abu Jawad, Jehad; Pöttgen, Christoph; Gauler, Thomas; Eberhardt, Wilfried; Arnold, G.; Grehl, Sara; Pfortner, R.; Schmeling, C.; Mohr, Christopher; Stuschke, Martin;

P6-9 Neoadjuvante Radiochemotherapie beim lokal fortgeschrittenen Mundhöhlenkarzinom : Vergleich der Langzeitergebnisse zweier Protokolle
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,

In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl.1, S. 99 - 100

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Kleinhans, J.; Jendrossek, Verena; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin;

Prognostisches Modell für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,

In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl 1, S. 17

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Nogova, L.; Gardizi, M.; Bos, M.; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L.; Schildhaus, H. U.; Fuhr, U.; Sos, M.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Thomas, R.; Buttner, R.; Wolf, J.;

TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,

In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 92

ISSN: 2296-5262

Online Volltext: dx.doi.org/
Nogova, Lucia; Gardizi, Masyar; Bos, Marc Christiaan Allardt; Scheffler, Matthias; Mattonet, Christian; Heukamp, Lukas Carl; Schildhaus, Hans-Ulrich; Fuhr, Uwe; Eberhardt, Wilfried; Reis, Henning; Wiesweg, Marcel; Schmid, Kurt Werner; Schoch, Gernot; Ko, Yon-Dschun; Serke, Monika Heidi; Schuler, Martin H.; Büttner, Reinhard; Wolf, Jürgen

TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation

In: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15, Suppl., S. 8109

ISSN: 0732-183X; 1527-7755

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Freitag, Lutz; Abu Jawad, Jehad; Gkika, E.; Wohlschläger, Jeremias; Welter, Stefan; Hoiczyk, M.; Schuler, Martin; Stamatis, Georgios; Eberhardt, Wilfried; Stuschke, Martin;

Vergleich von pCR und mediastinalem Downstaging als Surrogat- Marker für das Langzeit-Überleben von Patienten mit lokal fortgeschrittenem nicht-kleinzelligen Lungenkarzinom (NSCLC) nach neoadjuvanter Radiochemotherapie (RT/CT) und Resektion (Trimodalität)
20. Jahreskongress der Deutschen Gesellschaft für Radioonkologie (DEGRO), 3. bis 6. Juli 2014, Düsseldorf,

In: Strahlentherapie und Onkologie Jg. 190 (2014) Nr. Suppl. 1, S. 17

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Wiesweg, Marcel; Ting, Saskia; Reis, Henning; Worm, K.; Kasper, Stefan; Bauer, Sebastian; Gauler, Thomas; Welt, Anja; Richly, Heike; Tewes, Mitra; Meiler, Johannes; Hense, Jörg; Eberhardt, Wilfried; Derks, Christian; Cortes-Incio, D.; Skottky, S.; Wohlschläger, Jeremias; Breitenbucher, F.; Freitag, Lutz; Stamatis, Georgios; Schmid, Kurt Werner; Schuler, Martin;

WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,

In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 2 - 3

ISSN: 2296-5262

Online Volltext: dx.doi.org/
Schumann, C.; Engel-Riedel, W.; Kollmeier, J.; Grohe, C.; von Pawel, J.; Eberhardt, Wilfried; Gutz, S.; Nimmrich, I.; Weiss, C.; Potzner, M.; Serke, M.; Thomas, M.;

A multi-centric, open-label, phase II study investigates the combination of RAD001 (everolimus) with paclitaxel and carboplatin in first line treatment of patients with advanced (stage IV) Large Cell Lung Cancer with Neuroendocrine Differentiation (LCNEC)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,

In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 252

ISSN: 0378-584X; 1423-0240

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Eberhardt, Wilfried; Graupner, B.; Theegarten, Dirk; Gauler, Thomas; Freitag, Lutz; Abu Jawad, Jehad; Wohlschläger, Jeremias; Welter, Stefan; Stamatis, Georgios; Stuschke, Martin;

Akzeleriert-hyperfraktionierte Radiotherapie (RTx) mit simultaner Chemotherapie (CTx) im neoadjuvanten Konzept bei Stadium-III-Lungenkarzinom : signifikant höhere Rate pathologisch kompletter Remissionen (pCR) im Vergleich mit konventioneller Fraktionierung
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,

In: Strahlentherapie und Onkologie Jg. 189 (2013) Nr. Suppl. 1, S. 19

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Abu Jawad, Jehad; Gkika, E.; Berkovic, Katharina; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin;

Akzelerierte Post-Pneumonektomie Salvage-Bestrahlung (RTx) mit simultaner Chemotherapie (CTx) bei Patienten mit kontralate - ralen zentralen Lungenkarzinomrezidiven
DEGRO 2013 19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,

In: Strahlentherapie und Onkologie Jg. 189 (2013) Nr. Suppl. 1, S. 67

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Stuschke, Martin; Pöttgen, Christoph; Gauler, Thomas; Friedel, G.; Kohlhaufl, M.; Hehr, T.; Budach, W.; Bamberg, M.; Welter, Stefan; Stamatis, Georgios; Fischer, B.; Jöckel, Karl-Heinz; Eberhardt, Wilfried;

Compliance-Analyse der prospektiv-randomisierten multizentrischen ESPATÜ-Studie – lassen sich Patienten lieber operieren?
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,

In: Strahlentherapie und Onkologie Jg. 189 (2013) Nr. Suppl. 1, S. 87

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Griesinger, F.; Falk, M.; Conradi, I.; Halbfass, V.; Reinhardt, M.; Kluge, A.; Willborn, K. C.; Prenzel, R.; Scriba, D.; Henke, R. P.; Eberhardt, Wilfried; Hallas, C.; Tiemann, M.;

Pathologic complete remission after induction chemotherapy and intercalated Erlotinib in EGFR-mutated adenocarcinoma stage IIIA : Case report
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,

In: Onkologie Jg. 36 (2013) Nr. Suppl. 7, S. 253 - 254

ISSN: 0378-584X; 1423-0240

Online Volltext: dx.doi.org/
Griesinger, F.; Falk, M.; Conradi, I.; Halbfass, V.; Reinhardt, M.; Kluge, A.; Willborn, K.; Prenzel, R.; Scriba, D.; Henke, R. P.; Eberhardt, Wilfried; Hallas, C.; Tiemann, M.;

Pathologic complete remission after induction chemotherapy and intercalated erlotinib in EGFR-mutated adenocarcinoma stage IIIA : CASE REPORT
15th World Conference on Lung Cancer, October 27 - 30 2013, Sydney, Australia,

In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. S1169 - S1170

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/
Nel, I.; Gauler, Thomas; Nickel, A.; Eberhardt, Wilfried; Thomale, Jürgen; Schuler, Martin; Hoffmann, A.;

Prä-therapeutische ex-vivo Reparatur Kinetiken von Cisplatin-DNA-Addukten in Zirkulierenden Tumorzellen als Platin-Resistenz Test
119. Kongress der Deutschen Gesellschaft für Innere Medizin e.V., 06. - 09. April 2013, Wiesbaden,

In: Der Internist Jg. 54 (2013) Nr. Suppl. 1, S. 95 - 96

ISSN: 0020-9554

Online Volltext: dx.doi.org/
Nogova, L.; Gardizi, M.; Bos, MCA; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L. C.; Schildhaus, H. U.; Fuhr, U.; Sos, M. L.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Thomas, R. K.; Buttner, R.; Wolf, J.

TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation

In: Onkologie / Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich Jg. 36 (2013) Nr. Suppl. 7, S. 30

ISSN: 0378-584X; 1423-0240

Online Volltext: dx.doi.org/
Mitchell, P. L.; Butts, C. A.; Socinski, M. A.; Thatcher, N.; Wickart-Johansson, G.; Ellis, P. M.; Gladkov, O.; Pereira, J. R.; Eberhardt, Wilfried; Horwood, K.; Szczesna, A.; Helwig, C.; Schroder, A.; Shepherd, F. A.;

Tecemotide (L-BLP25) in unresectable stage III non-small cell lung cancer in the phase III start study : Further endpoint and exploratory biomarker results
15th World Conference on Lung Cancer, October 27 - 30 2013, Sydney, Australia,

In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. S135 - S136

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/
Nogova, L.; Bos, M.; Gardizi, M.; Scheffler, M.; Papachristou, I.; Wompner, C.; Heukamp, L. C.; Schildhaus, H.; Fuhr, U.; Sos, M. L.; Eberhardt, Wilfried; Wiesweg, Marcel; Schmid, Kurt Werner; Schuler, Martin; Buttner, R.; Wolf, J.

Try : a phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small-cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation

In: Journal of Thoracic Oncology Jg. 8 (2013) Nr. Suppl. 2, S. S914 - S915

ISSN: 1556-1380; 1556-0864

Online Volltext: dx.doi.org/ (Open Access)
Abu Jawad, Jehad; Grehl, Sara; Pöttgen, Christoph; Pfoertner, R.; Eberhardt, Wilfried; Gauler, Thomas; Arnold, G.; Mohr, Christopher; Stuschke, Martin;

Vergleich einer neoadjuvanten Radiochemotherapie mit Docetaxel/Cisplatin/5-FU oder mit Cisplatin alleine beim lokal fortgeschrittenen Mundhöhlenkarzinom
19. Jahreskongress der Deutschen Gesellschaft für Radioonkologie Berlin, 9. bis 12. Mai 2013,

In: Strahlentherapie und Onkologie Jg. 189 (2013) Nr. Suppl. 1, S. 100

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Theegarten, Dirk; Gauler, Thomas; Graupner, B.; Pöttgen, Christoph; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried; Freitag, Lutz; Welter, Stefan; Abu Jawad, Jehad

Accelerated Hyperfractionated Radiation Therapy Within Trimodality Therapy Concepts for Stage IIIa/b Non-small Cell Lung Cancer : Markedly Higher Rate of Pathologic Complete Remissions Than With Conventionally Fractionated Radiochemotherapy

In: International Journal of Radiation Oncology*Biology*Physics Jg. 84 (2012) Nr. 3, Suppl., S. S154

ISSN: 0360-3016

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Goer, S.; Koitsch, R.; Abu Jawad, Jehad; Gkika, E.; Berkovic, Katharina; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin

Einfluss der Induktions-Chemotherapie auf die Parameter der hochdosierten Radiochemotherapie beim lokal fortgeschrittenen Lungenkarzinom

In: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. 1 Suppl., S. 96

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Christoph, Daniel C.; Asuncion, Bernadette Reyna; Wynes, Murry; Gauler, Thomas C.; Wohlschläger, Jeremias; Theegarten, Dirk; Welter, Stefan; Tran, Cindy; Hassan, Biftu; Loewendick, Heike; Peglow, Anja; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.

Folylpoly-α-glutamate synthetase and thymidylate synthase are associated with clinical outcome from pemetrexed-based therapy in advanced non-small cell lung cancer (NSCLC)

In: Cancer Research / AACR 103rd Annual Meeting 2012 ; Mar 31‐Apr 4, 2012, Chicago Jg. 72 (2012) Nr. 8, Suppl., S. 1713

ISSN: 0008-5472; 1538-7445

Online Volltext: dx.doi.org/
Grehl, Sara; Eberhardt, Wilfried; Pöttgen, Christoph; Abu Jawad, Jehad; Kaelberlah, Hans-Peter; Gauler, Thomas; Arnold, G.; Mohr, Christopher; Stuschke, Martin

Neoadjuvante Therapie beim lokal fortgeschrittenen Mundhöhlenkarzinom : Induktionschemotherapie mit Docetaxel/Cisplatin/5-FU gefolgt von simultaner Strahlentherapie plus Docetaxel/Cisplatin gefolgt von OP – Phase-I-Studie: Ergebnisse und 3J-FU

In: Strahlentherapie und Onkologie Jg. 188 (2012) Nr. 1 Suppl., S. 90 - 90

ISSN: 0179-7158; 1439-099X

Online Volltext: dx.doi.org/
Pöttgen, Christoph; Abu Jawad, Jehad; Gkika, E.; Berkovic, Katharina; Gauler, Thomas; Eberhardt, Wilfried; Stuschke, Martin

Postpneumonectomy Radical Accelerated (Re-)irradiation and Concurrent Chemotherapy for Patients With Contralateral Central Lung Cancer Relapses

In: International Journal of Radiation Oncology, Biology, Physics / American Society for Radiation Oncology 54th Annual Meeting; 28-31 October 2012; Boston, USA Jg. 84 (2012) Nr. 3, Suppl. 1, S. 598

ISSN: 0360-3016

Online Volltext: dx.doi.org/
Schirmacher, P.; Eberhardt, Wilfried; Thomas, M.; Dietel, M.; Schütte, W.; Zirrgiebel, U.; Graf von der Schulenburg, J.M.; Gutendorf, B.

Mutation Testing and First Line Treatment of Patients With Advanced NSCLC and Positive EGFR Mutation Status – Results From a German Registry

In: European Journal of Cancer Jg. 47 (2011) Nr. Suppl. 1, S. S636

ISSN: 0959-8049

Online Volltext: dx.doi.org/
O'Byrne, K.; von Pawel, J.; Vynnychenko, I.; Eberhardt, Wilfried; De Marinis, F.; Paz-Ares, L.; Goddemeier, T.; Schumacher, K.; Gatzemeier, U.; Pirker, R.;

1stCycle rash as a Clinical Marker of outcome in Patients with advanced Non-Small Cell Lung Cancer (NSCLC) receiving 1st-Line Chemotherapy (CT) plus Cetuximab : Analysis by Histology
35th ESMO (European Society for Medical Oncology) Congress. Milan, Italy. October 8-12, 2010,

In: Annals of Oncology Jg. 21 (2010) Nr. Suppl. 8, S. 131 - 132

ISSN: 0923-7534; 1569-8041
Reck, M.; Stieglmaier, J.; Thomas, M.; Eberhardt, Wilfried; Engel-Riedel, W.; Waller, C.; Harbeck, N.; von Pawel, J.;

ASA404 (a Tumor-VDA) in advanced solid tumors : an update on clinical trials
29. Deutscher Krebskongress. Berlin 24.-27. Februar 2010,

In: Onkologie Jg. 33 (2010) Nr. Suppl. 2, S. 154 - 154

ISSN: 0378-584X; 1423-0240; 2296-5270; 2296-5262

Online Volltext: dx.doi.org/
Bischof, H.; Serke, M.; Reck, M.; Eberhardt, Wilfried; Schutte, W.; Fischer, J.; von Pawel, J.; Eschbach, C.; Gutz, S.; Schumann, C.; Heinzmann-Groth, I.; Zaun, S.; Thomas, M.;

Baseline population description of the German patient population in the EPICLIN-Lung epidemiological study in Non-Small Cell Lung Cancer (NSCLC) across Europe
29. Deutscher Krebskongress. Berlin 24.-27. Februar 2010,

In: Onkologie Jg. 33 (2010) Nr. Suppl. 2, S. 129 - 130

ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270

Online Volltext: dx.doi.org/
Wynes, M. W.; Dziadziuszko, R.; Singh, S.; Christoph, Daniel; Ranger-Moore, J.; Szostakiewicz, B.; Dziadziuszko, K.; Eberhardt, Wilfried; Jassem, J.; Hirsch, F. R.

Increased Thymidylate Synthase (TS) Gene Copy Number in NSCLC

In: Journal of Thoracic Oncology Jg. 5 (2010) Nr. 5 Suppl. 1, S. S56

ISSN: 1556-0864; 1556-1380

Online Volltext: dx.doi.org/
Eberhardt, Wilfried; Gauler, Thomas; W German Tumour Ctr;

Neoadjuvant therapy in stage III
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,

In: Onkologie Jg. 33 (2010) Nr. Suppl. 7, S. 102 - 103

ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270

Online Volltext: dx.doi.org/
Gauler, Thomas; Eberhardt, Wilfried;

Peritoneal mesothelioma
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,

In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 12 - 13

ISSN: 0378-584X; 1423-0240; 2296-5270; 2296-5262

Online Volltext: dx.doi.org/
Griesinger, F.; Bearz, A.; Eberhardt, Wilfried; Garrido, P.; Isla, D.; Ko, Y.; Kohlhaeufl, M.; Schneider, C.; Thatcher, N.; Pavlakis, N.;

Safety of First-Line Bevacizumab (BV)-Based Therapy in the Sail (MO19390) Trail : Central Tumour Locazion (CTL) and Hypertension (HTN) in Patients (PTS) with advanced Non-Small Cell Lung Cancer (NSCLC)
35th ESMO Congress, Milan, Italy 8–12 October 2010,

In: Annals of Oncology Jg. 21 (2010) Nr. Suppl. 8, S. 144

ISSN: 0923-7534; 1569-8041
Schutt, P.; Eberhardt, Wilfried;

Targeted therapy for patients with thyroid cancer
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,

In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 214

ISSN: 0378-584X; 1423-0240; 2296-5270; 2296-5262

Online Volltext: dx.doi.org/
Gottschling, S.; Herpel, E.; Eberhardt, Wilfried; Gatzemeier, U.; Fischer, J. R.; Kohne, C. H.; Kortsik, C.; Kuhnt, T.; Muley, T.; Meister, M.; von Romer, K. S.; Bischoff, H.; Schnabel, P. A.; Penzel, R.; Thomas, M.;

The gefitinib Long-Term Survivor (LTS) - a species on its own? : Molecular and clinico-pathological characteristics of German Long-Term Survivors treated in the Iressa Expanded Access Program (EAP)
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 1.–5. Oktober 2010, Berlin,

In: Onkologie Jg. 33 (2010) Nr. Suppl. 6, S. 103 - 103

ISSN: 0378-584X; 1423-0240; 2296-5262; 2296-5270

Online Volltext: dx.doi.org/

Beiträge in Sammelwerken und Tagungsbänden

Eberhardt, Wilfried; Van Schil, Paul E.; Curran, Walter; Socinski, Mark A.

Stage iiib non-small cell lung cancer

In: Principles and Practice of Lung Cancer: The Official Reference Text of the International Association for the Study of Lung Cancer (IASLC) / Pass, Harvey I. (Hrsg.) 2012, S. 821 - 836

ISBN: 978-0-7817-7365-2

ZIM

Zentrum für Informations- und Mediendienste

Personensuche

Personensuche

Dr. med. Wilfried Eberhardt

Funktionen

Mitglied/er, Innere Klinik (Tumorforschung)

Aktuelle Veranstaltungen

2023 SS

Vergangene Veranstaltungen (max. 10)

2022 WS

2022 SS

Artikel in Zeitschriften

Vorworte / Nachworte

Abstracts

Beiträge in Sammelwerken und Tagungsbänden